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ZUSAMMENFASSUNG 
 
Die neuromuskuläre Synapse (NMS) ist ein geeignetes Modell-System zur Untersuchung der 
molekularen Mechanismen während der Synaptogenese. Für die Bildung und 
Aufrechterhaltung der NMS ist das postsynaptische Transmembranprotein, MuSK (Muscle-
specific kinase) wichtig. MuSK ist eine Rezeptortyrosinkinase, die überwiegend in 
ausgereiften NMS konzentriert ist. Agrin, ein von Motorneuronen synthetisiertes 
Proteoglycan, wird in die synaptische Basallamina ausgeschüttet, wo es postsynaptische 
Differenzierung initiiert und dadurch auch die Phosphorylierung, die zytoskeletale 
Verankerung und die Aggregation von Acetylcholin-Rezeptoren (AChR) veranlasst. Der 
Agrin-Rezeptor, Lrp4 (LDL-receptor-related protein 4) ist ein Mitglied der LDLR Familie 
und bildet einen Komplex mit MuSK. Aufgrund dieser Komplexbildung führt die Aktivierung 
von Lrp4 durch Agrin auch zur Phosphorylierung von mehreren Tyrosinen in der 
intrazellulären Domäne von MuSK. Diese MuSK-Phosphorylierungen führen zur Aktivierung 
von MuSK, welche essenziell für die präsynaptische und postsynaptische Differenzierung ist. 
MuSK, Lrp4 oder Agrin „knock-out“ Mäuse sind nicht lebensfähig und sterben unmittelbar 
nach der Geburt, an respiratorischer Insuffizienz, da sie keine NMS bilden können. Außerdem 
sind AChR und weitere synaptische Proteine in diesen „knock-out“ Mäusen gleichmäßig 
entlang der Muskelfasern verteilt. Wie die Signale, die zur Aggregation von AChR führen, 
von aktiviertem MuSK weitergeleitet werden, ist größtenteils unbekannt und erfordert 
weitergehende Untersuchungen. Daher ist die Identifizierung und Charakterisierung von 
MuSK-Bindungspartnern von großer Bedeutung. 
 
Für die Identifizierung bis dato unbekannter Bindungspartner von MuSK wurde ein „Yeast-
Two-Hybrid (Y2H) Screen“ durchgeführt. Dafür wurde die zytoplasmatische Domäne von 
MuSK als „bait“ (Köder) und eine Muskel-cDNA Bibliothek als „prey“ (Beute) verwendet. 
Dabei wurde ein Protein, vorläufig Cl-6 genannt, gefunden, das spezifisch mit MuSK 
interagiert und ein neues Gen repräsentiert. Eine Analyse der Sequenz ergab, dass Cl-6 in 
seinem C-terminalen Teil über eine Vps9 Domäne verfügt, die homolog zur katalytischen 
Domäne des „guanine nucleotide exchange factors“ (GEF) Vps9p ist. Zusätzlich besitzt Cl-6 
noch eine Src homology 2 (SH2) Domäne, die für die Interaktion mit phosphorylierten 
Tyrosin Resten benötigt wird, und eine RIN homology (RH) Domäne, die ein 
charakteristisches Merkmal für die Familie der RIN Proteine ist. Alle drei bekannten RIN 
Proteine besitzen wie Cl-6 auch eine SH2 und eine Vps9 Domäne. Die Vps9 Domäne ist in 
allen drei RIN Proteinen aktiv und wirkt als GEF für Rab5. Es konnte gezeigt werden, dass 
die RIN Proteine in Endozytose- und vesikuläre Transportprozesse involviert sind. Daher 
scheint es auch wahrscheinlich, dass Cl-6 eine Rolle in vesikulären Transportmechanismen 
spielen könnte. Wegen der spezifischen Bindung von Cl-6 an MuSK, lässt sich weiters auf 
eine mögliche Beteiligung von Cl-6 in MuSK-Transportprozessen schließen. 
 
Im Rahmen dieser Diplomarbeit wurde die Interaktion von Cl-6 mit MuSK und Rab5 
untersucht und zusätzlich die Effekte einer Herunterregulierung von Cl-6 in Muskelzellen 
beobachtet. Es konnte gezeigt werden, dass die Interaktion von Cl-6 mit MuSK abhängig von 
der RH Domäne des Cl-6 Proteins ist, was die Ergebnisse eines vorangegangen „Y2H 
screens“ bestätigt. Die Vps9 Domäne wurde als Interaktionsdomäne für Rab5 gefunden und 
es konnte gezeigt werden, dass Cl-6, wie auch RIN1, spezifisch mit der dominant-negativen 
Mutante, S34N, von Rab5 interagiert. Schließlich wurde mit Hilfe von stabil transfektierten 
Muskelzelllinien gezeigt, dass eine spezifische Herunterregulierung von Cl-6 mittels „RNA 
interference“ (RNAi), zu einer verminderten Aggregation der AChR führt. Dieses Ergebnis 
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führt zu der Schlussfolgerung, dass Cl-6 eine wichtige nachgeordnete Komponente im 
Agrin/Lrp4/MuSK Signalweg ist, welche einen Einfluss auf die Zusammenlagerung der 
AChR an der NMS hat. Mithilfe dieser Zelllinien können nun auch die Funktion von Cl-6 
selbst und weitere Konsequenzen der Herunterregulierung der Proteinexpression von Cl-6 
noch genauer in Augenschein genommen werden. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  6 
ABSTRACT 
 
The neuromuscular synapse (NMS) is used as a simple model system to study molecular 
mechanism during synaptogenesis. The formation and maintenance of the NMS requires the 
postsynaptic transmembrane protein, MuSK (muscle-specific kinase). MuSK is a receptor 
tyrosine kinase, which is located predominantly at the NMS of mature muscle. Agrin is a 
proteoglycan, which is synthesized by motor neurons and gets secreted into the synaptic basal 
lamina, where it initiates postsynaptic differentiation and leads to the phosphorylation, the 
cytoskeletal linkage and the aggregation of acetylcholine receptors (AChRs). The receptor of 
Agrin, Lrp4 (LDL-receptor related protein 4), which is a member of the LDLR family, builds 
a complex with MuSK. Therefore, the activation of Lrp4 by Agrin leads to the 
phosphorylation of multiple tyrosine residues in the intracellular domain of MuSK. Due to 
phosphorylation, MuSK is activated, which is essential for presynaptic and postsynaptic 
differentiation. MuSK, Lrp4 or Agrin knock-out mice are nonviable and die shortly after birth 
due to respiratory failure since they fail to form NMS. In addition, AChRs and other synaptic 
proteins are uniformly distributed along the muscle fibers in these knock-out mice. How 
activated MuSK relays the signals that lead to the aggregation of AChR, is still unclear and 
requires additional studies. Therefore, the identification and characterization of MuSK 
binding partners is extremely important. 
 
A yeast-two-hybrid (Y2H) screen was performed to identify so far unknown MuSK binding 
partners. For this purpose the cytoplasmic domain of MuSK has been used as bait, and a 
mouse muscle cDNA library as prey. Thereby, a protein, currently termed Cl-6, has been 
identified, which specifically interacts with MuSK and represents a novel gene. Sequence 
analysis revealed that Cl-6 possesses a Vps9 domain, which is homologous to the catalytic 
domain of the guanine nucleotide exchange factor (GEF) Vps9p, in its C-terminal part. 
Additionally, Cl-6 contains a Src homology 2 (SH2) domain, which interacts with 
phosphorylated tyrosine residues, and a RIN homology (RH) domain, which is a characteristic 
feature of the family of RIN proteins. Moreover, all of the three RIN proteins also have a SH2 
and a Vps9 domain. The Vps9 domain is active in all three RIN proteins and serves as GEF 
for Rab5. It has been shown, that the RIN proteins are involved in endocytosis and transport 
processes. Therefore, it seems likely that Cl-6 plays a role in vesicular transport processes. 
The specific binding of Cl-6 with MuSK further suggests that Cl-6 might be involved in 
transport processes of MuSK. 
 
In the context of this diploma thesis the interaction of Cl-6 with MuSK and Rab5 has been 
studied and additionally, the effects of Cl-6 downregulation in muscle cells have been 
investigated. It could be shown, that the interaction of Cl-6 with MuSK depends on the RH 
domain of Cl-6, which confirms the results of a previously performed Y2H screen. The Vps9 
domain has been found as interaction domain for Rab5 and it could be shown, that Cl-6, like 
RIN1, interacts preferentially with the dominant-negative mutant, S34N, of Rab5. Finally, it 
could be shown, with the help of stable transfected muscle cell lines that a specific 
downregulation of Cl-6 via RNA interference (RNAi) results in reduced clustering of AChRs. 
This result, leads to the conclusion, that Cl-6 represents an important component in the 
downstream signaling of the Agrin/Lrp4/MuSK signaling pathway, which influences the 
clustering of AChRs at the NMS. By means of these cell lines, the function of Cl-6 itself and 
further consequences of its downregulation can be investigated. 
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1. Introduction 
 
1.1. The Neuromuscular Synapse 
 
The site, where a motor neuron makes a contact with a skeletal muscle fiber, is called a 
neuromuscular synapse (NMS). The precise interaction between these two is critical for the 
transmission of chemical signals to muscle fibers, which leads to muscle fiber contraction. 
Each muscle fiber is innervated by a single motor axon. Therefore, the NMS is the preferred 
model system to study neuronal networks and the formation of synapses. But not only 
because of its relative simplicity, but also because of its large size and its unparalleled 
accessibility when compared to synapses in the brain, which are about 100 times smaller and 
much harder to access in vivo (Figure 1), the NMS is the best studied electrical synapse in 
vertebrates (Sanes and Lichtmann, 2001). 
 
 
 
Figure 1. The Neuromuscular Synapse. The NMS of an adult mouse (on the right) in comparison to 
three synapses of cultured mouse hippocampal neurons (on the left) shown at the same scale. The 
postsynaptic membrane is stained in red and the nerve terminal in green. (Picture modified from Sanes 
and Lichtmann, 2001)  
 
 
Additionally, the NMS is a particularly favourable synapse for studying synapse formation, 
for the following reasons: (1) it is geometrically simple; (2) developing and regenerating 
synapses can be experimentally manipulated in vivo with relative ease; (3) synapses between 
motor neurons and muscle cells can be studied in cell culture; (4) synaptic proteins can be 
readily purified from Torpedo electric organ, which is an abundant and homogenous source of 
neuromuscular-like synapses; and (5) gene expression can be altered and studied in detail in 
transgenic and mutant mice (Burden, 1998). Furthermore, α-bungarotoxin, the main 
component present in the deadly venom of Bungaris multicinctus, allows irreversible binding 
to muscle AChRs with high specificity (Berg et al., 1972). 
 
NMSs are not only the model system for synapse formation, but are also important targets of 
research, since they play a role in many neuronal and muscular dysfunctions like myasthenia 
gravis, Lambert Eaton syndrome, congenital myasthenic syndrome and the large group of 
muscle dystrophies. 
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1.1.1. Organization and Function 
 
The NMS is build up by an axon terminal that extends from the nerve body and is surrounded 
by a Schwann cell that produces an insulating myelin sheath around it, and a motoric endplate 
from a muscle fiber (Figure 2). 
Acetylcholine (ACh) is an important neurotransmitter that is released by motor neurons at the 
NMS after excitation of the motor neuron form the axonal terminal. ACh is responsible for 
the transduction of a nerve-derived signal into muscle contractions and binds reversibly to 
acetylcholine receptors (AChRs), which are highly concentrated on the postsynaptic 
membrane of mature NMSs. For the formation of such mature synapses a series of complex 
interactions between motor neurons, muscle fibers and Schwann cells is needed (Burden, 
2002). 
 
 
Figure 2. The Neuromuscular Synapse. Cartoon showing the organization of the NMS (Gloria Ikonge, 
Diploma thesis)  
 
 
1.1.2. Hallmarks of Synapse Formation 
 
The formation of the NMS is a highly complex process which involves several critical steps. 
It occurs during early embryonic development or after denervation of a muscle, when the 
nerve needs to re-establish the contact to the muscle. Characteristic for a fully mature NMS 
are the shallow depressions of the muscle cell membrane, which is invaginated further into 
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deep and regular folds, termed postjunctional folds (Figure 3) (Burden, 1998). In addition, the 
molecules in the presynaptic and postsynaptic membranes are precisely organized, which 
leads to an even higher differentiation of the NMS. This means that specific proteins are not 
equally distributed within the membranes, but are concentrated in spatial narrow regions. 
AChRs, MuSK and Rapsyn are localized to the crests of these postjunctional folds, whereas 
other proteins, including sodium channels, are enriched in the troughts of the postjunctional 
folds (Hall and Sanes, 1993). But also the nerve terminal is spatially organized. Synaptic 
vesicles are clustered, adjacent to poorly characterized specializations of the presynaptic 
membrane, termed active zones. These active zones, which are the sites of synaptic vesicle 
fusion, are organized at regular intervals and are aligned precisely with the mouths of the 
postjunctional folds (Burden, 1998). Moreover, changes like the clustering of nuclei to 
synaptic sites associated with an alteration in the expression level of synapse-specific genes 
contribute to the establishment of a fully mature synapse (Cohen et al., 1997). All together, 
these findings imply sophisticated mechanisms to regulate the formation and maintenance of 
this fully mature structure throughout the life of an organism. 
 
 
(A) 
Figure 3. Electron-Microscopical Picture of the NMS. (A) The prominent postjunctional folds (indicated 
by black arrows) of the muscle membrane are situated opposite the active zone of the nerve terminal. (B) 
AChRs are concentrated at the crests of these folds, indicated by a white arrow in. 
 NT, nerve terminal; M, Muscle; S, Schwann cell (Picture modified from Burden, 1998). 
(B) 
 
 
 
Multinucleated skeletal muscle fibers form during embryonic development (starting at ~E11 
in the mouse) by fusion of precursor myoblasts. Shortly after that (E12-E13 in the mouse), 
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motor axons grow into this developing muscle and form a main intramuscular nerve, which in 
mammals extends through the central region of the muscle, perpendicular to the long axis of 
the myotubes. Individual motor axons start branching and terminate adjacent to the main 
intramuscular nerve, resulting in a narrow, distinct endplate zone, marked by presynaptic 
nerve terminals, clusters of AChRs, and elevated levels of AChR gene expression, in the 
middle of the muscle (Burden, 2002). Until E14.5 only few AChR-rich clusters are detectable 
and their densities are mostly aneural, which means that they are not closely apposed by nerve 
terminals, but located in a central region of the muscle (Lin et al., 2001; Yang et al., 2001). 
Following innervation of skeletal muscle fibers by the nerve, there is a redistribution of these 
clusters until they are trapped in a narrow, distinct region termed endplate zone (Luo et al., 
2003). This process is completed at E16-E18. 
 
Figure 4. Maturation of the Postsynaptic Apparatus. (A) AChR microcluster coalesce to form a loose 
aggregate. Late in embryogenesis, the aggregate consolidates to form a plaque: its borders sharpen, its 
length decreases, and AChR density increases. Postnatally, the plaque becomes perforated to eventually 
form a pretzel-like array of branches. The branches then expand in an intercalary fashion as the muscle 
grows. Change in AChR colour denotes the switch from γ- to ε-containing AChRs. (B) As these changes 
occur, the plaque is intended to form a gutter, then invaginated to form folds. AChRs are concentrated at the 
crests of the folds.  
E, embryonic day; P, postnatal day (Sanes and Lichtmann, 2001). 
(A) 
(B) 
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Although these neonate NMSs are functional even before birth, the postsynaptic membrane of 
neonates is very different from that of the adult. During maturation of the neonate synapse 
into the adult mature synapse, several changes can be observed (Figure 4). (1) The shape of 
the NMS changes from a simple oval plaque into a pretzel-like set of branches. (2) The 
initially flat junctional membrane changes into an invaginated surface with gutters and folds. 
(3) There is a quantitatively and qualitatively change in the composition of the basal lamina, 
that overlies the AChR-rich membrane and of the cytoskeletal apparatus that underlies it. (4) 
The composition of AChR changes from an embryonic form, containing γ-subunits, into an 
adult form, containing ε-subunits. Together with this change in subunit composition, also the 
properties of the channel change. There is a decrease in the channel opening times, whereas 
the channel conductance and its Ca2+ permeability increase. (5) Ion- and ligand-gated 
channels, along with their associated cytoskeletal elements, segregate into discrete alternating 
domains. Equally significant changes take place on the presynaptic site of the maturing NMS. 
There the nerve terminals become more efficacious, motor axons myelinate, and axonal 
braches are removed, leaving just one axon at each NMS (reviewed in Sanes and Lichtmann, 
2001). 
 
 
1.2. Agrin, MuSK and Lrp4 – The Key Players of Synapse Formation 
 
Motor nerve terminals at the NMS release a protein called Agrin (Nitkin et al., 1987). Agrin 
activates a receptor complex on myotubes. This complex consists of a transmembrane 
receptor tyrosine kinase called MuSK (muscle-specific kinase) (Valenzuela et al., 1995) and 
Lrp4 (LDL-receptor-related protein 4) (Kim et al., 2008; Zhang et al., 2008). The activation of 
this complex leads to the phosphorylation and activation of MuSK, which triggers 
postsynaptic differentiation and induces the aggregation of synapse-specific components at 
the site of innervation. Especially, the clustering of AChRs at the motor endplate to a density 
of up to 20 000 receptors per μm2 (in comparison with extrasynaptic regions with ~10 
receptors per μm2) can be seen as a hallmark of synapse formation (Figure 5) (Burden, 2002; 
Hughes et al., 2006). 
 
This increased density of AChRs is achieved by three distinct processes: (1) clustering of 
diffusely distributed AChRs in the postsynaptic membrane; (2) transcriptional activation of 
AChR subunit genes in subsynaptic nuclei; and (3) transcriptional repression of AChR 
subunit genes in nonsynaptic myonuclei (Hughes et al., 2006). 
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 Figure 5. Model for MuSK Signaling. This cartoon shows the activation of MuSK through Agrin. Lrp4 is 
responsible for Agrin-dependent MuSK activation. This activation leads then to the clustering of AChRs at 
the postsynaptic membrane. The process of how this is actually achieved remains unknown. 
Muscle cell
Agrin 
LRP4 
MuSK 
P P 
P P P P
AChR
Rapsynclustering 
kinases ?? 
 
 
1.2.1. Agrin 
 
An extracellular matrix protein was found by McMahan and colleagues that contained an 
activity to stimulate AChR aggregation. They used the electric organ of Torpedo californica 
as a source for their study, because it has a concentration of cholinergic synapses far greater 
than that of skeletal muscle (Smith et al., 1987). Due to this clustering ability, the protein was 
named Agrin, from the Greek word ‘agrein’ meaning ‘to assemble’ (Nitkin et al., 1987). In all 
of the species from which Agrin has been cloned, the gene encodes a protein of more than      
2 000 amino acids with a predicted molecular mass of 225 kDa. Agrin is extensively N- and 
O-glycosylated at the amino-terminal half and this increases the apparent molecular mass of 
Agrin to ~600 kDa (Figure 6). Due to the fact, that at least three of this carbohydrate 
attachment sites function as docking sites for heparin sulphate glycosaminoglycan side chains, 
Agrin has been assigned to the family of heparin sulphate proteoglycans (Tsen et al., 1995). In 
addition, Agrin contains nine follistatin-like domains which bear homology to Kazal-type 
protease inhibitor domains in its amino terminal half and four epidermal growth factor (EGF)-
like signaling domains and three laminin G-like domains in the carboxy-terminal region 
(Rupp et al., 1991; Tsim et al., 1992). The C-terminal region is sufficient to induce AChR 
clustering in cultured myotubes (Ruegg and Bixby, 1998), whereas the amino terminal region 
is thought to be responsible for the association of Agrin with the extracellular matrix 
(McMahan, 1990; Tsen et al., 1995). 
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Figure 6. Structural Domains of Agrin. The schematic representation of Agrin shows its structural domains, 
the most important interaction partners and their binding regions indicated above the domain structure. In 
addition, the sites for alternative mRNA splicing (A/y, B/z) are shown below the domain structure. Usage of 
alternative first exons results in the synthesis of Agrin isoforms, that are either NtA- (N-terminal Agrin) 
domain-containing and secreted or that remain membrane associated due to a single transmembrane (TM) 
region. The secreted Agrin isoform is the one localized to the NMS, and the signal sequence (SS) is the region 
responsible for its release.  
EG, epidermal growth factor-like domain; FS, follistatin-like domain; LE, laminin EGF-like domain; LG, 
laminin globular domain; NCAM, neuronal cell adhesion molecule; S/T, serine/threonine-rich region; SEA, sea 
urchin sperm protein, enterokinase, Agrin domain (Bezakova and Ruegg, 2003).
 
Agrin is produced by motor neurons, transported in motor axons and released at synaptic 
sites, where it organizes postsynaptic differentiation (McMahan, 1990; Ruegg and Bixby, 
1998) and also regulates the distribution of other synaptic proteins, including acetylcholine 
esterase (AChE), Rapsyn, utropin, neuregulin (NRG) and NRG receptors (ErbBs) (Apel et al., 
1995; McMahan, 1990; Meier et al., 1997). This Agrin hypothesis, which was formulated by 
McMahan (McMahan, 1990) is supported by the following findings. (1) Agrin knock-out 
mice can not form functional postsynaptic structures and die immediately after birth due to 
respiratory failure (Gautam et al., 1996). (2) Agrin treatment of cultured muscle cells induces 
postsynaptic-like differentiation (Wallace, 1989). (3) Injection of expression plasmids or 
purified recombinant Agrin into non-synaptic regions of innervated rodent muscle establishes 
a fully functional, mature postsynaptic apparatus in vivo and activates synapse-specific gene 
transcription (Bezakova et al., 2001; Jones et al., 1997). This reveals that Agrin is one of the 
essential key factors involved in NMS formation. 
 
The Agrin mRNA can be detected in various tissues and cells of the body, including central 
nervous system (CNS), peripheral nervous system (PNS), skeletal muscle, lung, kidney, 
Schwann cells and glia cells (Bezakova and Ruegg, 2003). Due to alternative splicing, several 
isoforms of Agrin occur, that differ in their tissue distribution and AChR clustering efficiency 
(Ferns et al., 1993; Ferns et al., 1992; Ruegg et al., 1992). Differential splicing at the 5’ end 
results in two different isoforms named SS-NtA-Agrin and TM-Agrin which differ in their 
localization, since only the SS-NtA-Agrin isoform can bind to laminins in the extracellular 
matrix. While SS-NtA-Agrin is the predominant isoform at the NMS, the TM-Agrin is 
abundantly expressed in the CNS. Two important splice sites in the C-terminus are called Y 
and Z sites. Insertion of small splice-inserts at these sites gives rise to isoforms that contain 0 
or 4 amino acids at the Y site, and 0, 8, 11, or 19 amino acids at the Z site. The insert at the Y 
site is required for heparin binding and modulates the binding of Agrin to α-dystroglycan 
(Gesemann et al., 1996), whereas the inserts at the Z site are crucial for Agrin-induced AChR 
aggregation (Burgess et al., 1999). On cultured myotubes, only the isoforms that contain an 
insert at the Z-site (Z+) induce AChR aggregation and this activity is absent when the insert at 
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the Z-site (Z-) is missing (Ruegg and Bixby, 1998). This splicing is also regulated in a tissue-
specific manner. The main source for the ‘active’ Agrin-Z+ isoforms (those that can induce 
aggregation) is neurons, including motor neurons, whereas transcripts from all non-neuronal 
cells, except Schwann cells, encode ‘inactive’ Agrin-Z- isoforms (Bezakova and Ruegg, 
2003). The isoform of Agrin, containing the four amino acid insert at the Y site in addition to 
the Z+ is more active in clustering of AChRs compared to Agrin lacking the Y insert (Glass et 
al., 1996). 
 
 
1.2.2. MuSK 
 
The muscle-specific kinase (MuSK) is a receptor tyrosine kinase specifically expressed in 
skeletal muscle. MuSK is expressed at low levels in proliferating myoblasts, but its 
expression is significantly upregulated after differentiation of myoblasts into myotubes and 
during muscle development. In mature muscle, MuSK is downregulated, and remains 
concentrated only at synaptic sites (Valenzuela et al., 1995). 
 
All receptor tyrosine kinases (RTKs) contain an extracellular ligand binding domain, a single 
transmembrane helix and a cytoplasmic domain that contains a conserved protein tyrosine 
kinase core. Ligand binding to the extracellular part of the RTKs induces the dimerization of 
the receptors and results in autophosphorylation of their cytoplasmic domains (Schlessinger, 
2000), which is responsible for activation of intracellular signaling cascades. 
 
The extracellular domain of mammalian MuSK contains four immunoglobulin-like (Ig-like) 
domains and a cysteine rich domain between the third and fourth Ig-like domain. The 
cytoplasmic domain is most similar to the kinase domains of the Trks, which are the receptors 
for neurotrophins (Valenzuela et al., 1995). It consists of the juxtamembrane region and the 
tyrosine kinase domain (Figure 7). Activation of MuSK leads to the phosphorylation of six of 
the nineteen tyrosine residues in the intracellular domain (Watty et al., 2000). From these six 
phosphotyrosines, especially Y553 within the juxtamembrane region seems to be especially 
important, since mutation of this tyrosine residue abrogated the ability of Agrin to induce 
clustering or tyrosine phosphorylation of AChRs in cultured myotubes. This tyrosine appears 
to have a dual function in MuSK signaling, since it is required for fully activation of MuSK 
kinase activity, as well as for the recruitment of signaling component(s) that functions 
downstream of MuSK (Herbst and Burden, 2000). Furthermore it turned out that the 
juxtamembrane region of MuSK, including a single phosphotyrosine docking site, even in the 
context of a different kinase domain, is sufficient to activate the multiple pathways that lead 
to presynaptic and postsynaptic differentiation in vivo (Herbst et al., 2002). 
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Figure 7. Schematic Drawing of the MuSK Protein. MuSK contains four immunoglobulin-like (Ig-like) 
domains and one cysteine-rich (C6) domain in its extracellular portion which, is separated from the 
intracellular part by a single transmembrane domain (TM). The cytosolic domain can be divided into a 
juxtamembrane (JM) domain and a kinase domain (TK). Tyrosines in these two domains become 
phosphorylated in response to Agrin. Tyrosine 553, which lies within an NPXY motif in the JM domain, has 
been shown to be essential for AChR clustering.   
 
 
MuSK is unusual among RTKs (Glass et al., 1997) in two ways: (1) Agrin can stimulate the 
rapid phosphorylation of MuSK, but needs an accessory complex, because it can not bind 
MuSK directly (DeChiara et al., 1996; Glass et al., 1996); (2) ligand-dependent activation is 
insufficient to mediate its effects (Glass et al., 1997; Jones et al., 1997). Therefore, Sanes and 
colleagues proposed a model in which the ectodomain of MuSK not only mediates ligand-
dependent activation of a complex signal transduction pathway, but also directs ligand-
independent localization of a multi-molecular AChR-containing complex to the postsynaptic 
membrane (Zhou et al., 1999). 
 
Mice deficient in MuSK lack normal NMSs. They are immobile, can not breathe and die at 
birth due to respiratory failure (DeChiara et al., 1996), like Agrin mutant mice (Gautam et al., 
1996). This similar phenotype of MuSK and Agrin mutant mice, at least at birth, formed the 
basis that MuSK is a component of an Agrin receptor complex (Burden, 2002). Earlier in 
development (E14), however, AChR clusters are evident and concentrated in the central 
region of muscle from Agrin mutant mice (Lin et al., 2001; Yang et al., 2001), whereas AChR 
clusters are absent from MuSK mutant mice at all stages of development. This indicates that 
AChR clusters can form in the absence of Agrin, but not in the absence of MuSK. 
Furthermore, it has been shown, that Agrin counteracts the ‘antisynaptogenic’ influence of 
ACh and is therefore necessary for the maintenance of AChRs but not for their clustering 
(Misgeld et al., 2005). 
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1.2.3. Lrp4 
 
It has been known for some time that Agrin was not able to interact directly with MuSK. 
Therefore a hypothetical molecule, myotube-associated specificity component (MASC) was 
proposed to serve as a binding partner for Agrin to transduce signals to MuSK (Glass et al., 
1996). 
 
In a genetic screen for genes that regulate early development in the mouse, mice carrying 
mutations in Lrp4 were found to have massive defects in neuromuscular synapse formation, 
leading to neonatal lethality (Weatherbee et al., 2006). LDL-receptor-related protein 4 (Lrp4) 
is a member of the LDLR family and contains a large extracellular N-terminal region that 
possesses multiple EGF and LDLR repeats, a transmembrane domain, and a short C-terminal 
region without an identifiable catalytic motif (Zhang et al., 2008). Members of this family are 
well known for their roles in lipid metabolism, cholesterol homeostasis and Wnt signaling (He 
et al., 2004; Schneider and Nimpf, 2003) and some also have specific roles in the 
development and function of the mammalian nervous system (May and Herz, 2003). 
The defects in presynaptic and postsynaptic differentiation are strikingly similar to those 
found in MuSK mutant mice, namely the absence of postsynaptic AChR clusters, extensive 
aberrant presynaptic branching, and reduced formation of presynaptic terminals. In addition to 
that, Lrp4 is expressed preferentially by muscle synaptic nuclei (Weatherbee et al., 2006), 
binds to neuronal, but not muscle Agrin and is required for Agrin to stimulate MuSK 
phosphorylation (Zhang et al., 2008). Moreover, Lrp4 self-associates, forms a complex with 
MuSK independent of Agrin and can reconstitute Agrin-stimulated MuSK phosphorylation in 
nonmuscle cells that express Lrp4 and MuSK (Kim et al., 2008). Because of its self-
association, Lrp4 may promote trans-phosphorylation and activation of MuSK, which can 
lead to the low level of Agrin-independent MuSK activation, which is needed for 
prepatterning (Figure 8). 
 
 
Figure 8. Working Model of the Interaction of MuSK-Lrp4 and Agrin. In the absence of neuronal 
Agrin, Lrp4 could interact with MuSK and this interaction is increased by Agrin stimulation. Such 
interaction is necessary for MuSK activation and the downstream signaling that leads to AChR clustering.  
P, phosphorylation (Zhang et al., 2008).  
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1.2.4. Downstream Signaling 
 
The signaling downstream of MuSK is not fully understood yet. Several proteins have been 
shown to be necessary, but how the signal is transmitted remains unclear. Figure 9 shows a 
schematic drawing of the signaling complex downstream of MuSK. 
 
 
Figure 9. Cartoon of the NMS with Associated Proteins. Activation of MuSK upon Agrin binding 
induces clustering and tyrosine phosphorylation of AChRs required for synaptic transmission. The AChR-
associated protein Rapsyn interacts with Calpain in an Agrin-dependent manner. Upon Agrin stimulation, 
the Agrin receptor Lrp4 induces MuSK phosphorylation and subsequent activation of several intracellular 
proteins. For further information see text.  
 
 
Rapsyn is an entirely intracellular protein that binds to AChRs in a 1:1 stoichiometry at the 
NMS (LaRochelle and Froehner, 1986). It interacts with the intra- and extracellular domains 
of MuSK in distinct ways, with the latter probably indirectly via a hypothetical protein termed 
RATL (for Rapsyn Associated Transmembrane Linker) (Apel et al., 1997). It also links the 
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AChRs to the dystroglycan/utrophin glycoprotein complex (Apel et al., 1995; Fuhrer et al., 
1999) and indirectly to the α-catenin-associated cytoskeleton, through its interaction with     
β-catenin (Zhang et al., 2007). In mice lacking Rapsyn, NMSs fail to form, demonstrating that 
Rapsyn is required for the aggregation of AChRs and also critical for organization of the 
postsynaptic cytoskeleton (Gautam et al., 1995). Rapsyn has also been shown to stabilize 
AChR clusters at the NMS by its interaction with Calpain, which inhibits the protease activity 
of Calpain and therefore the dispersion of AChR clusters in an Agrin-dependent manner 
(Chen et al., 2007). Rapsyn is also able to link AChR clusters to F-actin via its interaction 
with α-Actinin, which has been shown to play a role in Agrin-mediated AChR clustering 
(Dobbins et al., 2008). 
 
Other important proteins are Dok-7 and ShcD which both bind to the juxtamembrane NPXY 
motif of MuSK in a phosphorylation-dependent manner via their phosphotyrosine-binding 
domains (PTB domain) and therefore may compete for this binding site (Jones et al., 2007; 
Okada et al., 2006) and Tid1 which binds to the cytoplasmic domain of MuSK (Linnoila et 
al., 2008). Dok-7 is a cytoplasmic protein that is essential for MuSK activation in cultured 
myotubes. Mice lacking Dok-7 fail to form NMSs and die shortly after birth. Dok-7 appears 
to be involved in the propagation of signals from MuSK to its downstream effectors (Okada et 
al., 2006). Tid1 (for tumorous imaginal discs 1) is a heat shock protein (hsp) 40 homolog and 
has been implicated in a variety of signaling pathways, including those involving tyrosine 
phosphorylation. It binds to MuSK independently of Agrin and is required for both 
spontaneous and Agrin-induced AChR clustering in myotubes and for the maintenance of 
clusters at synapses in adult muscle fibers. Tid1 has been shown to be necessary for the 
interaction between Dok-7 and MuSK following Agrin stimulation, which is thought to lead 
to the activation of Tid1. Therefore, Tid1 appears to act downstream of Dok-7 in the signaling 
pathway (Linnoila et al., 2008). Shc family proteins serve as phosphotyrosine adaptor 
molecules in various receptor-mediated signaling pathways. ShcD appears to be primarily 
expressed in brain and skeletal muscle of adult mice.  It is co-expressed with MuSK in the 
postsynaptic region of the NMS and seems to play a role in the early tyrosine phosphorylation 
of the AChRs (Jones et al., 2007). 
 
The β-subunit of the protein kinase Casein kinase II (CKII) was identified as a protein that 
interacts with the phosphorylated intracellular domain of MuSK at the NMS. Additionally, the 
CKII-mediated serine phosphorylation of MuSK is important for normal AChR aggregation 
and maintenance (Cheusova et al., 2006). CKII is a highly conserved, ubiquitously expressed 
serine/threonine kinase present in all eukaryotes. It consists of a tetramer of two catalytic 
(α/α’) and two regulatory (β) subunits. In mice, the knock-out of the gene encoding the 
CKIIβ subunit is lethal at a very early embryonic stage (Buchou et al., 2003). 
 
Other important molecules that have been found to play a role in signal transduction 
downstream of MuSK and Agrin include tyrosine kinases like Abl kinases (Finn et al., 2003) 
and Src-family kinases (Mohamed et al., 2001; Sadasivam et al., 2005), Dishevelled 
(Dvl)/p21-activated kinase (PAK1) (Luo et al., 2002), geranylgeranyltransferase I (GGT1), 
which is a zinc metalloenzyme and tethers proteins to plasma membrane by prenylation (Luo 
et al., 2003), Rac and Cdc42, small GTPases of the Rho family (Weston et al., 2000) and 
Syne-1 (Apel et al., 2000). 
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1.3. Cl-6 a Novel MuSK-Interaction Partner and a Potential Guanine 
Nucleotide Exchange Factor for Rab5 
 
The newly identified protein, currently termed Cl-6, was isolated in a yeast-two-hybrid (Y2H) 
screen with a mouse muscle cDNA library, using the MuSK cytoplasmic region as bait 
protein. Figure 10 shows a scheme of this originally identified protein and its domains. 
 
 
Figure 10. Scheme of the Cl-6 Protein (Y2H) and Its Functional Domains.  
Vps9, guanine nucleotide exchange factor domain; RH, RIN homology domain. 
RH Vps9 1 380
 
 
This new protein contains a Vps9 domain in its C-terminal part, which is homologous to the 
catalytic domain of the guanine nucleotide exchange factor (GEF) Vps9p. This Vps9 domain 
is highly conserved and present in a number of multidomain proteins and is well known for its 
function as a GEF for Rab5 (Hama et al., 1999). In addition to this, Cl-6 contains a RH (RIN 
homology) domain, which is shared by the members of the RIN family. Database search using 
a sequence alignment tool identified striking sequence homology of Cl-6 and the three 
described RIN proteins, which have been described only recently (see chapter 1.4). All of 
them contain a functional Vps9 domain, serve as GEF for Rab5 and seem to be involved in 
endocytosis and vesicular transport (Kajiho et al., 2003; Saito et al., 2002; Tall et al., 2001). 
Sequence alignment with the RIN proteins, resulted in high sequence homology of RIN Src 
homology 2 (SH2) domains and the N-terminal part of Cl-6, although a SH2 domain was not 
assigned to Cl-6 by database predictions. The SH2 domain represents a protein-binding 
module that recognizes phosphorylated tyrosines (pTyr). Therefore, proteins containing this 
domain play different roles in cellular tyrosine kinase signaling pathways. 
 
The interaction of Cl-6 with MuSK was confirmed in a heterologous cell system and it turned 
out that the kinase activity of MuSK is not required for this interaction (Michaela Mutzl, 
Diploma thesis). In Y2H experiments, the region containing the RH domain turned out to be 
essential for the interaction of Cl-6 with MuSK (Ruth Herbst, unpublished data) and 
expression of Cl-6 in fibroblasts gives a punctuated staining pattern, which indicates a 
localization of this protein in vesicles or endosomes (Barbara Woller, Diploma thesis). The 
same intracellular localization was described for the RIN proteins (Kajiho et al., 2003). 
Taking into account the functional properties of the described RIN proteins, Cl-6 might play a 
role in MuSK trafficking, most likely in endocytosis. Furthermore, Cl-6 has been shown to be 
highly concentrated at the NMS and further co-localizes with AChRs, which is a prerequisite 
for a potential function during Agrin/MuSK signaling (Barbara Woller, Diploma thesis). 
 
Analysis of the expression pattern of Cl-6 revealed that the highest expression level is found 
in spleen, lung and thymus, which suggests that Cl-6 might also play a role in the immune 
system. Additionally, lower levels of Cl-6 are found in kidney, liver, heart and brain and the 
lowest levels were found in muscle tissue (Gloria Ikonge, Diploma thesis). 
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1.4. The Family of RIN Proteins 
 
RIN stands for Ras interaction/interference and results from the fact that RIN1 was originally 
identified as an inhibitor of activated Ras (Colicelli et al., 1991). Ras is a membrane-
associated small G-Protein that is directly coupled to both receptor and non-receptor tyrosine 
kinases. RIN proteins contain a functional Ras association (RA) domain (Han and Colicelli, 
1995; Han et al., 1997). It has been shown that RIN1 directly competes with RAF1 for 
binding to H-Ras (Han and Colicelli, 1995; Wang et al., 2002) and that each RIN interacts 
with certain types of Ras members (Kajiho et al., 2003). So far this family consist of three 
members namely RIN1, RIN2 and RIN3 (Figure 11). Within the central region of these three 
proteins a conserved 100 amino acid sequence has been found and subsequently termed RIN 
homology (RH) domain (Saito et al., 2002). 
 
 
 
Figure 11. Scheme of the RIN Proteins and Cl-6 with the Functional Domains. Numbers below the 
schemes represent the amino acid residue.  
SH2, Src homology domain 2; PRDs, proline-rich domains; RH, RIN homology domain; Vps9, guanine 
nucleotide exchange factor domain; RA, Ras association domain (Picture modified from Kajiho et al., 
2003). 
RIN1 
Cl-6 
RIN2 
RIN3 
 
 
 
Further studies revealed that RIN1 also contains a region homologous to the catalytic domain 
of Vps9p-like Rab guanine nucleotide exchange factors (GEFs) (Tall et al., 2001). Rab 
GTPases are members of the Ras superfamily and represent key regulators of membrane 
trafficking and receptor localization in eukaryotic cells (see chapter 1.5). It has been shown, 
that Rab5 can be activated by the action of Vps9p (Hama et al., 1999). It turned out, that this 
Vps9p catalytic domain is necessary and sufficient for the interaction of RIN1 with GDP-
bound Rab5. RIN1 was also shown to stimulate Rab5 guanine nucleotide exchange, Rab5a-
dependent endosome fusion, and epidermal growth factor (EGF) receptor-mediated 
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endocytosis. Furthermore, the stimulatory effect of RIN1 on all three processes is potentiated 
by activated Ras (Tall et al., 2001). Additionally, RIN1 interacts with 14-3-3 proteins through 
the Ras binding domain (RBD), with the SH3 domain of signal-transducing adaptor molecule 
2 (STAM2) and Abl tyrosine kinase through its Proline-rich domain, the latter leading to 
tyrosine phosphorylation of RIN1 by c-Abl (Han et al., 1997), and with the EGFR through its 
SH2 domain (Kong et al., 2007). 
 
RIN2 is an additional Rab5-binding protein and has been identified due to its sequence 
similarities to RIN1 (Saito et al., 2002). This protein functions as a tetramer, composed of 
anti-parallel linkage of two parallel dimers. It has the same structure as RIN1 accept for an 
additional Proline-rich domain. In contrast to RIN1, it preferentially binds to the GTP-bound 
form of Rab5, although it enhances the guanine exchange reaction of Rab5. Therefore, it may 
not only function as an upstream GEF but also as a downstream effector for Rab5 in the 
endocytic pathway. Additionally, it turned out that the RH domain, together with the Vps9 
domain, constitutes a region necessary for Rab5 binding (Saito et al., 2002). 
 
The same group also identified RIN3, which shares many functional domains with the other 
RIN proteins and contains three Proline-rich domains. They found that RIN3 has the same 
biochemical properties as RIN2, the stimulator and stabilizer of GTP-Rab5. In addition RIN3 
exhibits its unique intracellular localization and localizes to Rab5-positive, but not EEA1 
(early endosomal antigen 1)-positive vesicles, which is an early endosomal marker. With its 
Proline-rich domain, RIN3 interacts with amphiphysin II, which is involved in receptor-
mediated endocytosis and cytosolic amphiphysin II is translocated into RIN3- and Rab5-
positive vesicles. Altogether, this indicates that RIN3 plays an important role in the transport 
pathway from plasma membrane to early endosomes (Kajiho et al., 2003). 
 
 
1.5. Rab Proteins – a Family of Small GTPases 
 
Rab GTPases resemble the largest family of small GTPases. They function as molecular 
switches that change between two conformational states, an active, GTP-bound and an 
inactive, GDP-bound state. More than 60 members of the Rab family have been found and 
they act as coordinators of vesicle trafficking. They are localized to distinct intracellular 
membranes. Therefore, the specificity of vesicle trafficking is encoded in the machinery itself 
(Bock et al., 2001). 
In Figure 12 the cycle of Rab proteins is depicted. (1) The newly synthesized Rab protein, in 
the GDP-bound ‘inactive’ form, is recognized by a Rab escorting protein (REP) that presents 
the Rab protein to (2) a geranylgeranyl transferase (GGT), which geranylgeranylates the Rab 
on one or two carboxy-terminal cysteine residues. (3) This geranylgeranylated, GDP-bound 
Rab protein is recognized by Rab GDP dissociation inhibitor (GDI), which is involved in Rab 
GTPase delivery to and removal from membranes. Targeting of the Rab-GDI complex to 
specific membranes is mediated by interaction with a membrane-bound GDI-displacement 
factor (GDF), which catalyses both the dissociation of prenylated, GDP-bound Rab proteins 
from GDI, and the subsequent transfer of Rab proteins onto the membrane. (4) At the 
membrane, a guanine nucleotide exchange factor (GEF) catalyzes the exchange of GDP for 
GTP, which causes a conformational change of the Rab protein. (5) The GTP-bound ‘active’ 
form recruits or activates multiple effector proteins, including sorting adaptors, tethering 
factors, kinases, phosphatases and motors. These Rab effector proteins are not randomly 
distributed on the organelle membrane, but are clustered in distinct functional domains. 
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Therefore, they are primary determinants of compartmental specificity in the organelles of 
eukaryotic cells. (6) The GTP-bound Rab gets inactivated by GTP hydrolysis, which is 
stimulated by a GTPase-activating protein (GAP). These GAPs are necessary, since Rab 
proteins only have a low intrinsic rate of GTP-hydrolysis (Reviewed by Pfeffer and Aivazian, 
2004; Stenmark, 2009; Zerial and McBride, 2001). 
 
 
Figure 12. Schematic Drawing of Rab5 Activation and Inactivation. For information see text. 
REP, Rab escorting protein; GGT, geranylgeranyltransferase; GDI, GDP dissociation inhibitor; GDF, GDI 
displacement factor; GEF, guanine nucleotide exchange factor; GAP, GTPase-activating protein (Picture 
modified from Stenmark, 2009). 
(1) 
(2) 
(3) 
(4) 
(5) 
(6)
 
 
 
 
1.5.1. Rab5 
 
Rab5 is among the best studied Rab proteins to date and is known as the key regulator of 
endocytosis, where it is involved in clathrin-coated vesicle formation, fusion between early 
endosomes, endosomal cargo recruitment and endosomal motility (Zerial and McBride, 
2001). In mammalian systems, three Rab5 isoforms (a, b, c) have been documented, and 
several specific functions have been attributed to the distinct isoforms. For example, Rab5a 
can potentiate endocytosis of the epidermal growth factor receptor (EGFR), but Rab5b and 
Rab5c cannot. Phylogenetic analysis of the human Rab family suggests that Rab21, Rab22a 
and Rab22b might also belong to the Rab5 family. They co-localize with Rab5 and its 
effectors on early endocytic compartments (Carney et al., 2006). It has been shown, that Rab5 
generates microdomains on endosome surfaces, which comprise specific proteins and their 
lipid- and protein-binding partners (Zerial and McBride, 2001). Additionally, Rab5 has been 
shown to be necessary for Ras stimulated pinocytosis (Li et al., 1997), and also has a function 
in macropinocytosis (Pfeffer, 2005). Furthermore, Rab5 is rate-limiting for endocytosis and is 
regulated by PKB/Akt, a kinase coupled to signal transduction (Barbieri et al., 1998). 
The first direct effector of Rab5 that has been identified was Rabaptin-5, which is a mainly 
cytosolic protein, that is recruited to the membrane of early endosomes by GTP-bound Rab5 
and is required for membrane docking and fusion (Stenmark et al., 1995). In case of Rab5, it 
could be shown, that nucleotide exchange is essential for endosome fusion, since active Rab5 
is very unstable and rapidly hydrolysed by GAPs (Rybin et al., 1996). Therefore, only a small 
fraction of Rab5 is active on the membrane, which can recruit Rabaptin-5 to engage the 
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membrane docking and fusion machinery. Hence, the finding that Rabex-5, a Rab5 GEF, 
forms a tight complex with Rabaptin-5 at the membrane implies that this complex couples 
nucleotide exchange to effector recruitment. In addition to the activation of Rab5 by Rabex-5, 
this interaction with Rabaptin-5 stabilizes the activated Rab5 on the membrane by delaying 
GTP-hydrolysis (Horiuchi et al., 1997). Hama et al. showed that Vps9p in yeast serves as a 
GEF for Vps21p and the mammalian sequence homolog, Rab5. They concluded, that Vps9p 
and Rabex-5 may represent a novel class of GEFs that modulate the activity of Rab5 (Hama et 
al., 1999). It turned out that this consensus Vps9p catalytic domain is present in a variety of 
multi-domain proteins and that Alsin (ALS2) and a new family of proteins, the RIN proteins, 
which also contain these Vps9 domain, function as GEFs for Rab5. RIN1 was shown to bind 
to the GDP-bound form of Rab5, while the other two RIN proteins preferentially interact with 
the GTP-bound form (Kajiho et al., 2003; Saito et al., 2002; Tall et al., 2001). ALS2 showed a 
slight preference for the Rab5a isoform, but the significance of this observation remains 
unclear. Furthermore, ALS2 serves additionally as an exchange factor for Rac1 via its Dbl 
homology (DH) and Pleckstrin (PH) domains (Topp et al., 2004). The crystal structure of the 
Vps9 domain of Rabex-5 was determined, revealing that the catalytic core of Rabex-5 
exhibits high specificity for the Rab5 subfamily, and has a tandem helical architecture in 
which the Vps9 domain is stabilized by an essential helical bundle (Delprato et al., 2004). It 
has been shown that the Vps9 domain of Rabex-5 possesses GEF activity on only Rab5, 
Rab21 and more weakly Rab22 (Carney et al., 2006). It turned out, that GTP-bound Rab22 
serves as a binding site on early endosomes for direct recruitment of Rabex-5 and activation 
of Rab5. Therefore, Rabex-5 is an effector for Rab22 (Zhu et al., 2009). The presence of other 
signaling domains within Vps9 domain-containing proteins suggests that these GEFs might 
serve to integrate Rab5 activation with signal transduction cascades (Carney et al., 2006). 
Structural analysis of Rabex-5 further revealed the presence of an autoinhibitory element, that 
overlaps with the binding site for Rabaptin-5 and potently suppresses the exchange activity of 
Rabex-5 (Delprato and Lambright, 2007). 
 
Additionally, it turned out that some Rab5 effectors, namely Rabaptin-5 and Rabenosyn-5, 
actually act as bifunctional effectors of the GTPases Rab5 and Rab4. A cooperatively 
interaction of these two proteins seems to be required, to ensure a strong physical link 
between the Rab4 and Rab5 domains. Therefore, they may provide spatial control integrating 
Rab5-dependent fusion and Rab4-dependent fission events (De Renzis et al., 2002; Deneka 
and van der Sluijs, 2002). 
Other Rab5 interacting proteins are Rabankyrin, Vps34 and EEA1 (van der Bliek, 2005). 
 
 
1.6. RNA Interference 
 
1.6.1. Overview 
 
With the RNA interference (RNAi) technique genes can be silenced at the mRNA level, due 
to the inhibition of the expression of specific genes by double stranded RNAs (dsRNAs). 
With this methode the function of a gene both in vivo and in vitro can be quickly and easily 
determined. When exposed to foreign genetic material (RNA or DNA), many organisms 
mount highly specific counter attacks to silence the invading nucleic-acid sequences, before 
these sequences can integrate into the host genome or subvert cellular processes. Interestingly, 
dsRNA does more than help to defend cells against foreign nucleic acids – it also guides 
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endogenous developmental gene regulation, and can even control the modification of cellular 
DNA and associated chromatin (Mello and Conte, 2004). RNAi is a multi-step process 
involving the generation of small interfering RNAs (siRNAs) in vivo through the action of the 
RNase III endonuclease Dicer (Shi, 2002). The resulting 21- to 23-nucleotide (nt) siRNAs 
guide distinct protein complexes to their targets. These silencing complexes include the RNA-
inducing silencing complex (RISC), which pairs with the complementary mRNA sequences 
and leads to their degradation (Mello and Conte, 2004). 
 
 
 
Figure 13. The DNA Vector-Based RNAi Technology. (A) Generation of a small hairpin RNA (shRNA) 
directed by a Pol III promoter. The two motifs that form the inverted repeat are separated by a spacer and the 
resulting RNA is predicted to fold back forming a shRNA as shown (Shi, 2003). (B) The pSuper RNAi System; 
overview of the insert design. Custom oligos of 60 nt are cloned into the pSuper vector between the unique 
BglII and HindIII enzyme sites. The resulting transcript of the recombinant vector forms a 19 base pair stem-
loop structure that is quickly cleaved in the cell to form the functional siRNA (pSuper Manual, Oliqo Engine, 
2003). 
(A) 
(B) 
 
 
 
In vitro synthesized, 21 to 23 nt long dsRNAs can act as siRNAs to elicit gene-specific 
inhibition in mammalian cells. Lately, DNA-based plasmid vectors for the delivery of siRNA 
into mammalian cells have been described (Figure 13). With these vectors small hairpin 
RNAs (shRNAs) are transcribed, which can be processed into functional siRNAs by Dicer. In 
addition to providing a low-cost alternative to the chemically synthesized siRNAs, this DNA-
vector based strategy is capable of mediating stable target gene inhibition, thus allowing gene 
function analysis over an extended period of time. This approach appears to function in a 
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wide variety of cells, including established cell lines, such as NIH3T3, HeLa, HEK-293T and 
COS cells. However, in mammalian cells, siRNA-mediated gene inhibition, leads to a 
maximal reduction of 80-90% and never completely eliminates the target gene product. 
Therefore, it must be considered a ‘knock-down’ rather than a ‘knock-out’ approach (Shi, 
2002). 
 
 
1.6.2. pSuper and pSuperior RNAi System 
 
The pSuper RNAi system provides a mammalian expression vector (Figure 13) that directs 
the synthesis of siRNA-like transcripts. This vector uses the polymerase-III Histone1 (H1)- 
RNA gene promoter, as it produces a small RNA transcript lacking a polyadenosine tail. 
Additionally, the H1 promoter has a well-defined start of transcription and a termination 
signal consisting of five thymidines in a row (T5). Most importantly, the cleavage of the 
transcript at the termination site occurs after the second uridine, yielding a transcript 
resembling the ends of synthetic siRNAs, which also contain two 3’ overhanging T or U 
nucleotides (Brummelkamp et al., 2002). The pSuperior.gfp/neo vector carries EGFP and a 
neomycin resistance gene (Figure 14). 
 
 
Figure 14. The 
pSuperior.gfp/neo Vector. 
 
Length: 5429 bp 
 
Vector features: 
F1 origin 
PGK promoter 
Neomycin 
EGFP 
H1 promoter 
Ampicillin resistance 
 
Key sites: 
BglII (3181), HindIII (3187)
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2. Aim of the Project 
 
The aim of my diploma project was to characterize the role of Cl-6, a novel MuSK binding 
protein, in vitro. My work focused on four distinct goals: (1) to narrow down the binding site 
of Cl-6 with MuSK, (2) to investigate the interaction of Cl-6 with Rab5 and the region 
required on Cl-6 for this interaction, (3) to investigate the interaction between Cl-6 and 
endogenous MuSK expressed in muscle cells and (4) to determine the function of Cl-6 during 
Agrin-induced AChR clustering. 
 
The results of this study are described in the next chapter. 
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3. Results 
 
3.1. Interaction Studies of Cl-6 
 
3.1.1. Cloning of GST-Fusion Proteins 
 
Different Cl-6 constructs were cloned into glutathione S-transferase (GST) containing vectors 
to gain constructs with a N-terminal GST-Tag (see Materials and Methods). The cloning 
strategies are shown in Figure 15. 
 
 
Figure 15. Scheme of the Different GST-Fusion Protein Containing Plasmids.  For further information 
about the cloning procedure see Materials and Methods. 
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Figure 16 shows an overview of the Cl-6 truncation proteins, which were used for the pull-
down experiments. 
 
 
 
563 
563 
563 
563 
Cl-6 fl 1 
200 
479 200 
248 
398 538 
   487 398 
486 
Y2H 
N900 
Δ250 
Vps9 
Vps9a 
Vps9b 
Figure 16. Schematic Diagram of the Different Cl-6 Constructs Used for GST Pull-Downs. Numbers 
next to the schemes represent the amino acid residues.  
SH2, Src homology domain; RH, RIN homology domain; Vps9, guanine nucleotide exchange factor 
domain. 
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3.1.2. Expression and Purification of GST-Fusion Proteins 
 
3.1.2.1. Expression of GST-Fusion Proteins 
 
The different GST-fusion protein containing plasmids were transformed into the E. coli strain 
Rosetta and expression was induced by the addition of IPTG (see Materials and Methods). 
 
3.1.2.2. “Test Purifications” of GST-Fusion Proteins 
 
For the purification of the GST-fusion proteins glutathione-agarose beads were used. At first 
the protocol was adjusted to achieve good yields for all proteins. Therefore “test 
purifications” were performed with and without sarkosyl. This determination was important, 
because on one hand sarkosyl helps to keep the proteins soluble, but on the other hand it 
interferes with the binding of the GST-fusion proteins to the beads. After the purification 
aliquots were subjected to SDS-PAGE. The bands were then visualized by Coomassie 
Brilliant Blue staining. In Figure 17 examples of such purifications of two proteins are shown. 
In the case of the GST-Tag alone the purification works better without sarkosyl, but in the 
case of RIN1 sarkosyl is necessary. 
 
 
 
Figure 17. „Test Purifications“ of GST-Fusion Proteins. The GST-fusion proteins were expressed in 
Rosetta bacteria by induction with 0.5mM IPTG. Aliquots were taken before (BI) and after induction (AI). 
Comparing these two lanes successful induction of protein expression is observed. The bacteria were lysed 
and to some samples 0.25% sarkosyl was added before sonication. After a centrifugation step the clear 
lysates were diluted with lysis buffer to reduce the amount of sarkosyl and incubated with glutathione-
agarose beads. Aliquots taken during the purification procedure were run on a 10% SDS polyacrylamide gel 
and proteins were visualized by staining with Coomassie Brilliant Blue.  
M, marker; BI, before induction; AI, after induction; L, lysate; So, sonicated; C, centrifuged; Su, 
supernatant; B, beads. 
     BI AI L So C Su B M BI AI L So C Su B BI AI L So C Su B M BI AI L So C Su B 
+ sarkosyl - sarkosyl + sarkosyl - sarkosyl 
GST RIN1
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3.1.2.3. Large Scale Purifications of GST-Fusion Proteins 
 
With the “test purifications” the method was specified and also the amount of how much 
protein can be gained was determined. Therefore large bacterial cultures were used and 
treated in the way that had been proven to be the best. Again aliquots were collected and 
subjected to SDS-PAGE followed by Coomassie Brilliant Blue staining to determine the 
purity and the concentration of the proteins (Figure 18). 
 
 
 
 BI AI 1 2 5 8 12 M BI AI 2 4 10 16 24 M BI AI 2 4 10 16 24 M BI AI 2 4 10 16 24 
μl Beads μl Beads μl Beads μl Beads 
Figure 18.  Purifications of GST-Fusion Proteins. The GST-fusion proteins were expressed in Rosetta 
bacteria by induction with 0.5mM IPTG. Aliquots are shown before (BI) and after induction (AI). Aliquots 
of the purified proteins were separated by SDS-PAGE and proteins were visualized by staining with 
Coomassie Brilliant Blue.  
M, marker; BI, before induction; AI, after induction. 
GST Y2H Cl-6 RIN1 
 
 
3.1.3. Interaction of Cl-6 with Rab5 
 
COS-7 cells were transfected with different GFP-Rab5 constructs, namely wild type (wt), the 
dominant negative mutant (S34N) and the constitutively active mutant (Q79L). In addition 
GFP-Rab7 (wt) was used to test for specificity. Aliquots of pooled lysates expressing the 
same GFP-Rab protein were separated by SDS-PAGE and subjected to Western blot analysis 
to determine the expression of the different constructs within the cells (Figure 19). This 
experiment was necessary to include similar amounts of GFP-Rab within one GST pull-down 
experiment. 
 
 
 Blot: α-GFP 
Rab5 
S34N 
Rab5 
Q79L 
Rab7
wt 
Rab5 
wt 
Figure 19. Expression of Different Rab 
Constructs.  Lysates of C-7 cells transfected with 
GFP-Rab5 wt, S34N, Q79L or Rab7 were subjected 
to SDS-PAGE and Western blot analysis, using α-
GFP as antibody. The expression of Rab7 and Rab5 
wt was stronger compared to Rab5 S34N and Q79L. 
~55kDa 
GFP-Rab 
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For the pull-down experiments approximately equal amounts of GFP-Rab proteins were 
mixed with purified GST-fusion proteins coupled to the beads. Pull-downs were performed as 
described in Material and Methods. The samples were subjected to SDS-PAGE followed by 
Western blot analysis. Figure 20A shows that Cl-6 interacts specifically and robustly with the
dominant negative mutant of Rab5 (S34N) but not with the other Rab proteins that were
tested. Several control reactions were performed. Rab7 was used to check the specificity of
the binding between Cl-6 and Rab5. RIN1 served as a positive control, since it has already
been published, that RIN1 preferentially interacts with Rab5 S34N (Tall et al., 2001), and the 
 
 
 
 
 
 
 
 
 
GST alone was used to show that the interaction is specific and not due to cross-reaction via 
the GST-Tag or unspecific binding to the glutathione-agarose beads (Figure 20B). 
 
 
(B) 
Figure 20. Interaction of Cl-6 with Rab5. COS-7 cells were transfected with different GFP-Rab proteins. 
The cells were lysed and a GST pull-down was performed with the indicated GST-fusion proteins followed 
by immunoblotting with α-GFP (1:1000) and Ponceau staining. (A) The pull-down with Cl-6 fl is shown. 
(B) The pull-downs with RIN1 and GST are shown. (C) Two different volumes of lysates are shown to 
confirm that the amounts of GFP-Rab proteins that have been used are comparable. 
Red rectangles mark the used GST-fusion proteins. PD, pull-down; wt, Rab5 wt; S, Rab5 S34N; Q, Rab5 
Q79L; R7, Rab7. 
(C)
wt S Q R7 
Lysates 
(A) 
Cl-6 fl RIN1 GST 
Blot: α-GFP Blot: α-GFP 
wt S Q R7 
Ponceau 
Blot: α-GFP 
wt S Q R7 wt S Q R7
Ponceau 
Blot: α-GFP 
 
~55 kDa 
GFP-Rab
PD: 
Ponceau
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(A) (B) (C) 
Figure 21. Interaction of Deletion Constructs of Cl-6 with Rab5. COS-7 cells were transfected with 
different GFP-Rab5 constructs as mentioned. The cells were lysed and a GST pull-down was performed 
with the indicated GST-fusion proteins followed by immunoblotting with α-GFP (1:1000) and Ponceau 
staining. (A) Interactions of the Cl-6 constructs with the different Rab5 proteins are shown. (B) Results 
of the control experiments where the pull-downs were only performed with the GST-Tag are shown. (C) 
An aliquot of each lysate is shown to confirm that the amounts of GFP-Rab5 proteins that have been 
used are comparable.  
Red rectangles mark the used GST-fusion proteins. PD, pull-down; wt, Rab5 wt; S, Rab5 S34N; Q, Rab5 
Q79L. 
 
Blot: α-GFP 
Ponceau 
wt S Q wt S Q wt S Q wt S Q
Y2H N900 Δ250 Vps9 
wt S Q
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Blot: 
wt S Q
GST 
Blot: 
~55 kDa 
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-GFP -GFPα α
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To determine which parts of the Cl-6 protein are needed for its interaction with Rab5 S34N, 
different truncation mutants, namely Y2H, N900, Δ250 and Vps9 (see Figure 15), were used. 
Our predictions were that all but the N900 should be able to interact with Rab5, since all but 
the N900 contain the Vps9 domain. Again COS-7 cells were transfected with GFP-Rab5 (wt, 
S34N, Q79L) and after cell lysis subjected to a pull-down using the above described GST-
fusion proteins. Then the samples were separated by SDS-PAGE and Western blotting was 
performed using α-GFP antibodies (Figure 21). As expected, all Cl-6 constructs with the 
exception of N900, which lacks the Vps9 domain, did interact with Rab5 and all of them 
interacted specifically with the dominant negative mutant of Rab5 (S34N). In case of the 
Vps9 truncation only a very weak interaction was detectable. Crystallization structure 
previously revealed that a helical bundle N-terminal to the Vps9 domain, is needed for its 
function (Delprato et al., 2004). Therefore, this Vps9 truncation might not be fully functional 
and this might explain the weak interaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ponceau  
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l-6 was found as an interaction partner of the cytoplasmic region of MuSK in a Y2H screen 
uSK-myc and after lysis, the cell lysates were subjected to a pull-
own using the different purified GST-fusion proteins described in Figure 15. As shown in 
igure 22, Cl-6, Y2H, N900 and Δ250 interacted with MuSK, whereas the Vps9 constructs 
id not. CKII was used as a positive control, since it has been shown previously, that CKII 
teracts with MuSK (Cheusova et al., 2006). As expected, a strong interaction of CKII with 
uSK can be observed on the blot. Surprisingly, RIN1 also interacted with MuSK, similarly 
 Cl-6. 
 
 Red rectangles mark the used GST-fusion proteins. PD, pull-down; Lys, lysate. 
(C) 
3.1.4. Interaction of Cl-6 with MuSK 
 
C
and this interaction has been confirmed by co-immunoprecipitation and co-localization 
studies (unpublished data by Barbara Woller). Therefore, the next step was to determine the 
region within Cl-6 that is necessary for this interaction. For that purpose, HEK-293T cells 
were transfected with M
d
F
d
in
M
to
 
 
Figure 22. Interaction of Cl-6 with MuSK. HEK-293T cells were transfected with MuSK-myc. The cells 
were lysed and a GST pull-down was performed with the indicated GST-fusion proteins followed by 
immunoblotting with α-Myc (1:5000) and Ponceau staining. (A) The pull-down experiments with the 
different Cl-6 constructs are shown. (B) The pull-down experiments of the two controls, CKII and GST, and 
of RIN1 are shown. (C) An aliquot of the lysate is shown.  
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3.1.5. Interaction of Cl-6 with Endogenous MuSK of C2C12 Cells 
 
Since the GST pull-down experiments showed a specific and direct interaction between 
uSK-myc and Cl-6, we next asked, whether this interaction can also be detected with the 
ndogenous MuSK expressed in C2C12 muscle cells. Therefore, differentiated C2C12 cells 
were starved for 2.5 to 3 hours, treated with or without Agrin for 30min and then lysed. The 
lysates were subjected to a pull-down using GST fusion proteins. In this experiment Cl-6 was 
used as well as GST and CKII, which served as negative and positive control, respectively. As 
an additional control, cell lysates were immunoprecipitated with α-MuSK antibodies. As 
shown in Figure 23, no interaction between MuSK and Cl-6 can be detected. Although Agrin 
induces a strong phosphorylation of MuSK as detected with α-pY antibodies, no interaction 
of MuSK with CKII is observed. This is surprising since CKII has been found to interact 
preferentially with phosphorylated MuSK (Cheusova et al., 2006). All of the observed signals 
appear to be unspecific, since they are either above or below the MuSK signal which was 
gained by immunoprecipitation or signals are the same for GST as for CKII and Cl-6. This 
suggests that the pull-down is not sensitive enough to detect interactions between endogenous 
MuSK and GST-fusion proteins. 
 
 
M
e
(A) 
Agrin 
CKII GST Cl-6 
Ponceau 
 
Figure 23. Interaction of Cl-6 with Endogenous MuSK of C2C12 Cells. Differentiated C2C12 cells were 
treated with or without agrin and lysed. The lysates were then subjected to GST pull-downs with the 
indicated constructs or immunoprecipitation (IP) with α-MuSK (1:125) antibodies and followed by (A) 
immunoblotting (IB) with α-pTyr (Cell Signaling, p100 1:2000; Santa Cruz, p99 1:1000), α-MuSK (C.F.) 
and α-MuSK (H25, 1:250) antibodies and (B) Ponceau staining. 
Red rectangles mark the used GST-fusion proteins. 
- + - + - +
(B) 
MuSK 
MuSK 
MuSK 
  IP CKII GST Cl-6 
ΙΒ: α-pY
ΙΒ: α-MuSK (C.F.) 
ΙΒ: α-MuSK (H25) 
 - +  - + - + - +
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3.2. RNAi Experiments to Knock-Down Cl-6 Expression 
 
To study the function of Cl-6 an already established RNAi approach (Barbara Woller, 
Diploma thesis) was used, to kock-down the expression of Cl-6 and determine its influence on 
the clustering of AChRs. 
 
 
3.2.1. RNAi Oligos Targeting Cl-6 
 
To suppress Cl-6 expression, siRNA sequences were selected using different RNAi design 
tools. 
Three different sequences, located at position 348, 1529 and 2034 of the full-length Cl-6 
cDNA were chosen (Figure 24). 
 
 
 
 
 
Additionally, two constructs with the scrambled siRNA base pair composition located at 
position 348 and 2034 of the full-length Cl-6 cDNA were made, in order to test the specificity 
of suppression of Cl-6 expression and to produce a negative control for siRNA-mediated 
knock-down (Michaela Mutzl, Diploma thesis). 
 
 
istance in addition to its function of siRNA mediated 
ownregulation of gene translation. Cell lines expressing the different pSuperior constructs 
ere generated (Michaela Mutzl, Diploma Thesis). 
oper myotube formation as well as for the 
s (Figure 25). Positive clones showing normal 
yotube formation and expression of GFP are listed in Table 1. Only for two siRNA 
3.2.2. Selection of Clones with Stable siRNA Expression 
 
For analysis of Cl-6 function, several cell lines stably carrying the pSuperior.gfp/neo vector 
with different siRNA oligos were generated. The pSuperior.gfp/neo RNAi system expresses 
EGFP and has a neomycin res
d
w
The clones were expanded and tested for pr
presence of GFP in myotube cell lysate
m
PCR fragment 
Y2H Cl-6
~ 820bp ~ 2100bp 
3’ 5’ 
348 1529 2034 
Figure 24. Scheme of the Cl-6 cDNA with RNAi Oligos Targeting the Gene at Different Positions. 
Oligos 1529 and 2034 are located in the original Y2H cDNA sequence, 348 targets the Cl-6 5’-end (Barbara 
Woller, Diploma thesis). 
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constructs (348 and 2034) and two control constructs (empty and 2034 scrambled) GFP 
expression was detectable. 
 
 
 
Cell line Myotube formation GFP positive clones 
 
 
pSuperior-empty Normal 2A, 2B 
pSuperior-348 Normal 3A 
pSuperior-2034 Normal 5E 
pSuperior-2034 scrambled Normal 6L, 6O 
 
 
 
 
3.2.3. Role of Cl-6 in AChR Clustering 
e positive cell line of 
ach construct (2B, 3A, 5E, 6L) was used. For this purpose differentiation of the cells into 
2A 2B 3A 3C 3D 5E 6L 6N 6M 6O
 
To investigate the influence of endogenous Cl-6 on AChR clustering, on
e
myotubes was induced by applying differentiation medium containing G418. After 
differentiation into myotubes, the clustering of AChRs was induced by stimulation with Agrin 
and AChRs were visualized by staining with Alexa594-conjugated α-bungarotoxin (BTX). 
Myotubes were then fixed with 2% PFA and mounted using VectaShield (Vector Laboratories 
Inc.) or Mowiol. As shown in Figure 26A, the cell lines stably expressing the constructs 
containing the two siRNAs (348 and 2034) show a reduced AChR cluster length compared to 
the controls (empty and 2034 scrambled). 
 
~27kDa EGFP
Figure 25. Stable Cell Lines Carrying the pSuperior.gfp/neo Vector. C2 cells were transfected with 
Lipofectamine 2000 and selected using 700μg/ml G418 in the culture medium. Single clone colonies were 
picked, cells were again expanded and myotube cell lysates were subjected to immunoblotting (IB) with α-
GFP (Santa Cruz, 1:1000) antibody. 
2, pSuperior-empty; 3, pSuperior-348; 5, pSuperior-2034; 6, pSuperio-2034 scrambled; the letters just 
denote the different cell lines that have been tested. 
Table 1. Stable Cell Lines Containing pSuperior/RNAi Constructs.  
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8 hours 16 hours 
 
 
 
A detailed analysis was performed by measuring the AChR cluster length and counting the 
AChR cluster numbers. The number and the average length of AChR clusters were 
significantly decreased in the stable cell lines, which express the siRNA 348 or 2034 
compared to myotubes expressing pSuperior empty or 2034 scrambled (Figure 27A). In 
addition, the size distribution of AChR clusters was altered (Figure 27B). The number of 
microclusters was increased at the expense of large-size clusters (>10μm). The fraction of the 
medium sized clusters increased also a little bit but not as dramatically as the fraction of the 
microclusters. 
Many studies published by other researchers use 16 hours of Agrin stimulation. To test 
whether this treatment has the same effect, I stimulated myotubes for 16 hours (Figure 26B). I 
observed that a longer Agrin treatment leads to a reduction in the average cluster length and 
the number of cluster per myotube (compare Figure 27A and 28A) and also changes the size 
own. Clustering of AChRs was induced by incubation in 
nerve-derived Agrin-containing medium for (A) 8 or (B) 16 hours as indicated.  
Figure 26. Downregulation of Cl-6 Interferes with AChR Clustering. Representative images from 
different BTX-labeled C2 stable cell lines are sh
empty 
348 
2034 
2034 scr. 
pSuperior 
constructs 
(A) (B) 
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distribution of the AChR clusters (compare Figure 27B and 28B). In general, this longer 
treatment with Agrin reduced the difference seen between the RNAi treated and the control 
cell lines. 
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Figure 27. Downregulation of Cl-6 Leads to a Reduction of AChR Cluster Length and Number in 
Stable Cell Lines and Alters the Distribution of the Size of the AChR Clusters. Quantification of the 
effect after 8 hours of Agrin stimulation. (A) The average cluster length (on the right) and the number of 
clusters per 100μm myotube are shown. (B) All visible clusters were assigned to the three groups according 
to their size, and percentage of each group is shown. Error bars +/- 1.0 SEM (Standard error of mean). 
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Figure 28. Downregulation of Cl-6 Leads to a Reduction of AChR Cluster Length and Number in 
Stable Cell Lines and Alters the Distribution of the Size of the AChR Clusters. Quantification of the 
effect after 16 hours of Agrin stimulation. (A) The average cluster length (on the right) and the number of 
clusters per 100μm myotube are shown. (B) All visible clusters were assigned to the three groups according 
to their size, and percentage of each group is shown. Error bars +/- 1.0 SEM (Standard error of mean). 
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3.2.4. Agrin-Induced MuSK Phosphorylation in Muscle Cells Expressing 
Cl-6 RNAi 
 
To check whether Cl-6 downregulation also has an influence on MuSK expression and/or 
activation, differentiated myotubes were stimulated with or without Agrin and cells were 
lysed. The cell lysates were immunoprecipitated with α-MuSK followed by SDS PAGE and 
immunoblotting with α-pTyr and α-MuSK. An aliquot of each lysate was immunoblotted 
with α-Actin to check for equal loading (Figure 29). 
 
 
 
 
 
A quantification of the results from Figure 29 revealed that no strong effect on MuSK 
expression and phosphorylation can be observed when Cl-6 is downregulated by siRNAs 
(Figure 30). These data were only gained from one experiment and therefore need to be 
confirmed by further studies. 
 
 
 
 
 
+ - + - + - + -
 
 
 
 
 
 
 
 
 
Agrin 
empty 348 2034 2034 
scr. 
IP: α-MuSK 
IB: α-pTyr 
IB: α-MuSK 
MuSK 
MuSK 
Actin Lysates IB: α-Actin 
Figure 29. Expression and Phosphorylation of MuSK in C2 Stable Muscle Cell Lines. Lysates of stable 
cells lines were immuoprecipitated (IP) with α-MuSK (1:125) and immunoblotted (IB) with α-pTyr (Cell 
Signaling, p100 1:2000; Santa Cruz, p99 1:1000) and α-MuSK (1:250). To ensure that the same amount of 
lysate was used, an aliquot of the lysate was immunoblotted with α-actin. 
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Figure 30. MuSK Activation and Expression in C2 Cell Lines Expressing pSuperior/RNAi. 
Quantification of the data shown in Figure 29. (A) The expression of MuSK is shown as the ratio between 
the MuSK and the actin signals. (B) MuSK phosphorylation is shown as the fold induction after Agrin 
treatment, with values of unstimulated cells set to 1. 
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4. Discussion 
uSK represents the central key player during the development of the NMS. However, the 
ignaling cascade regulated by MuSK is not yet fully understood. Likewise, few direct 
teraction partner of MuSK have been identified, especially in comparison to RTKs, like 
GFR (epidermal growth factor receptor). Binding partners include Scr, Dishevelled, Syne-1, 
ok-7, Tid1, Abl and CKII (Apel et al., 2000; Cheusova et al., 2006; Finn et al., 2003; 
innoila et al., 2008; Luo et al., 2002; Mohamed et al., 2001; Okada et al., 2006; Sadasivam 
t al., 2005). 
his study focuses on a protein termed Cl-6, which was found as an interaction partner of 
uSK in a Y2H screen (Ruth Herbst, unpublished). The interacting regions of Cl-6 with 
uSK and Rab5 were narrowed down using a GST pull-down assay supporting the notion 
at this newly identified protein may play a role during MuSK and Rab5 functions. Another 
portant finding of this study was the observation that the targeting of Cl-6 with siRNAs 
ttenuates Agrin-induced AChR clustering. This suggests that Cl-6 is an important component 
f the Agrin/MuSK signaling pathway and plays an important role in AChR clustering at the 
MS. 
.1. Cl-6 – a Novel Member of the RIN Family 
atabase searches with Cl-6 revealed striking homologies to the three members of the RIN 
rotein family, RIN1, RIN2 and RIN3 (Han and Colicelli, 1995; Kajiho et al., 2003; Saito et 
l., 2002). In particular, the domain structure between the proteins appears highly conserved 
arbara Woller, Diploma thesis). Cl-6 shares the SH2, the Vps9 and most importantly also 
e RH (RIN homology) domain with the RIN proteins, but lacks proline rich domains and the 
A (Ras association) domain. Consequently, we propose that Cl-6 shares functional 
roperties with the members of the RIN family. 
.2. Interaction of Cl-6 with MuSK and Rab5 
 this study the interactions of Cl-6 with MuSK and Rab5 have been investigated. Figure 31 
hows a scheme summarizing these interactions. 
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MuSK Rab5 S34N 
+ + 
Interaction with 
 
 
teracts with MuSK. Although it has not been tested whether the interaction between MuSK 
it seems likely that the RH domain mediates 
er this interaction of RIN1 with 
3 are also able to interact with 
uSK through this domain. 
 between Cl-6 and the endogenous MuSK 
xpressed in C2C12 cells. We reasoned that this assay would be more specific since it does 
not depend on the overexpression of MuSK-myc in a heterologous cell system. However, I 
was unable to detect any interaction of Cl-6 with MuSK. There are several possible 
explanations. First of all, the GST pull-down assay has a limited sensitivity. A lot of MuSK 
protein was required to gain an interaction, which lead to the conclusion, that the amount of 
MuSK present in the C2C12 cells might have been too low. Secondly, we had to use a MuSK 
antibody for detection, which showed unspecific binding activity. In particular it recognized 
some other proteins of similar size as MuSK, making it difficult to check for the presence of a 
weak band eventually corresponding to MuSK. Furthermore, it was not possible to detect an 
interaction between CKII and endogenous MuSK. It has been reported that CKII interacts 
preferentially with the phosphorylated MuSK (Cheusova et al., 2006). I however, was never 
 31. Scheme of the Interactions of Cl-6 with MuSK and Rab5.  
+, interaction; -, no interaction; nd, not determined. 
 
 
4.2.1. Interaction of Cl-6 with MuSK-Myc and Endogenous MuSK of 
C2C12 Cells 
 
As shown in Figure 31, the Cl-6 truncations, which contain the RH domain, were able to 
interact with MuSK, namely Y2H, N900, Δ250. These results were consistent with a previous 
Y2H screen, in which the RH domain has also been indentified as the interacting domain of 
Cl-6 with MuSK (Ruth Herbst, unpublished data). Since the RH domain, which is shared by 
ll proteins of the RIN family, mediates this interaction, it is not surprising that RIN1 also a
in
and RIN1 depends on the RH domain of RIN1, 
this interaction. It would be interesting to determine, wheth
MuSK has any significance in vivo and if RIN2 and/or RIN
M
 
Additionally, we wanted to show the interaction
e
Figure
563 Cl-6 fl. 1 
563 
563 
563 
200 
479 200 
248 
398 538 
  487 398 
486 
Y2H 
N900 
Δ250 
Vps9 
Vps9a 
Vps9b 
+ 
- 
- 
- 
+ 
- 
nd 
nd 
+ 
+ 
+ 
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able to detect an interaction using either phosphotyrosine or MuSK antibodies. This further 
supports the notion that the GST pull-down is not suitable to detect interactions between Cl-6 
and the endogenous MuSK of C2C12 cells. 
 
 
4.2.2. Interaction of Cl-6 with Rab5 
 
Rab5 has already been shown to interact with the Vps9 domain of all three RIN proteins 
(Kajiho et al., 2003; Saito et al., 2002; Tall et al., 2001). Therefore, we hypothesized an 
interaction between the Vps9 domain of Cl-6 and Rab5. Using GST pull-down, only Cl-6, 
Y2H and Δ250 interacted with Rab5, while N900 and Vps9 did not (Figure 31). This result 
suggests that the classical Vps9 domain is required but not sufficient and that additional 
amino acids N-terminal of the Vps9 domain are essential. Indeed, it turned out that the 
predicted Vps9 domain, does not represent the whole Vps9 domain, but lacks the helical 
bundle. This has been shown for Rabex-5 by crystallization studies (Delprato et al., 2004) and 
also for RIN1 by Y2H screens (Tall et al., 2001). Therefore, the Δ250 construct represents the 
whole functional Vps9 domain, with the helical bundle and the classical Vps9 domain. 
Cl-6 interacted preferentially with the dominant negative mutant of Rab5, S34N, which has 
also been demonstrated for RIN1 (Tall et al., 2001), although the interaction between Cl-6 
nd Rab5 appeared weaker than between RIN1 and Rab5. In contrast, the other two member
f the RIN family, RIN2 and RIN3, have been shown to preferentially interact with the 
onstitutively active mutant of Rab5, Q79L, thereby stabilizing GTP-Rab5  (Kajiho et al., 
2003; Saito et al., 2002). It has been shown that all three RIN proteins have GEF (guanine 
et al., 2
ab5 is known as the key regulator of endocytosis, where it is involved in clathrin-coated 
a s 
o
c
nucleotide exchange factor) activity towards Rab5 (Kajiho et al., 2003; Saito et al., 2002; Tall 
001). 
R
vesicle formation, fusion between early endosomes, endosomal cargo recruitment and 
endosomal motility (Zerial and McBride, 2001).This GTPase is rate-limiting for endocytosis 
and is regulated by PKB/Akt, which is a kinase coupled to signal transduction (Barbieri et al., 
1998). GEFs of Rab5 can catalyze the exchange of GDP with GTP and thereby activate Rab5, 
which in turn can then activate or recruit effector molecules (Stenmark, 2009). For RIN1 it 
has been shown that it can interact with Rab5a, and that this interaction is necessary for 
EGFR endocytosis (Chen et al., 2009). Therefore, evidence that Cl-6 also possesses GEF 
activity for Rab5, would strongly indicate that Cl-6 plays a role in the endocytic processing of 
surface molecules, maybe of MuSK. 
 
 
4.2.3. RIN1 and Cl-6 
 
The observation that Cl-6 and RIN1 show the same interaction pattern regarding Rab5 and 
MuSK, suggests that Cl-6 might have a similar function in the cell as RIN1. RIN1 has been 
shown to interact with a variety of different proteins through its different functional domains. 
The SH2 domain is responsible for the interaction with activated receptors via 
phosphotyrosine residues and the proline rich domain is able to interact with SH3 domains. 
SH2 and SH3 domains are involved in the assembly of signal transducing protein complexes 
and in the regulation of non-receptor tyrosine kinases, such as Src and Abl (Han et al., 1997). 
Additionally, there are a Vps9 domain, which has been shown to serve as GEF for Rab5 (Tall 
et al., 2001) and the RA domain, which directly interacts with Ras (Colicelli et al., 1991). 
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The EGFR, the interleukin-3 (IL3) receptor, the insulin receptor and EphA4 receptor have 
been found as interaction partners of the SH2 domain of RIN1. Additionally, RIN1 has been 
hown to play an important role in the endocytosis and signaling of these receptor (Barbieri et 
l., 2003; Deininger et al., 2008; Hunker et al., 2006a; Hunker et al., 2006b). The interaction 
correct membrane localization (Galvis et al., 
 EGFR degradation in EGF-stimulated cells. 
onsistently, depletion of endogenous RIN1 by RNAi resulted in a remarkable reduction of 
 et al., 
2002). Activated Ras potentiates the stimulatory role of RIN1 on Rab5 guanine 
e viable and appear to develop normally, but show 
nhancement of aversive learning and memory. This suggests a negative modulating role for 
e Ras effector RIN1 in normal learning and memory (Dhaka et al., 2003). 
be highly expressed in the brain, although the expression of RIN1 
as not uniform in the whole brain. In addition, lower levels of RIN1 expression were found 
s
a
with activated EGFR may direct RIN1 to the 
2009). Overexpression of RIN1 accelerated
C
EGFR degradation. Additionally, signal-transducing adaptor molecule 2 (STAM2), which 
associates with hepatocyte growth factor-regulated substrate and plays a key role in the 
endosomal sorting machinery, was found as interaction partner of the proline rich domain of 
RIN1. This suggests that RIN1 regulates EGFR degradation in cooperation with STAM2, 
which defines a novel role for RIN1 in regulating endosomal trafficking (Kong et al., 2007). 
Other interaction partners of this proline rich domain are the Abl kinases, which bind via their 
SH3 domains (Han et al., 1997). However, Abl has been shown to phosphorylate a tyrosine 
(Y36) on RIN1 after interaction with the proline rich domain and this phosphorylated tyrosine 
residues interacts then with the SH2 domain of Abl (Hu et al., 2005). This interaction seems 
to promote a more accessible Abl catalytic site through relief of autoinhibition (Cao
2008). Recently, it has been shown, that RIN1 preferentially interacts with Rab5a and that 
Rab5a is needed for EGFR degradation (Chen et al., 2009). It would be interesting to 
determine, if Cl-6 also possesses a preference for any Rab5 isoform. 
 
RIN1 and Raf1 compete directly for binding to activated Ras. The normal localization and 
function of RIN1, but also its ability to compete with Raf1, are regulated in part by 14-3-3 
proteins, which act as negative regulators of RIN1 membrane localization and Ras association 
(Wang et al., 
nucleotide exchange, Rab5a-dependent endosome fusion and EGFR-mediated endocytosis 
(Tall et al., 2001). 
 
Ras signaling following its interaction with Raf is also known to mediate long-term 
potentiation (LTP) and long-term memory formation in postmitotic neurons. RIN1 seems to 
function through the competitive inhibition of Ras-Raf binding and leads to Ras signaling 
through alternate pathways. Additionally, it could be shown, that RIN1 is preferentially 
expressed in postnatal forebrain neurons in which it is localized in dendrites and physically 
associated with Ras. This suggests a role of RIN1 in Ras-mediated postsynaptic neuronal 
plasticity. RIN1 knock-out mice ar
e
th
 
RIN1 has been shown to 
w
also in pancreas, kidney, lung, liver and placenta (Han and Colicelli, 1995). Cl-6 on the other 
hand is most strongly expressed in spleen, thymus and lung and additionally, lower levels are 
found in kidney, liver, heart, brain and skeletal muscle (Gloria Ikonge, Diploma thesis). 
Giving the different expression pattern of Cl-6 and RIN1 they might have some 
complementary roles in different tissues. Therefore, it will be interesting to determine how 
Cl-6 behaves towards the other interacting proteins of RIN1 and how its function is regulated, 
since it lacks the RA domain, which has been shown to have a regulatory function on the GEF 
activity of RIN1(Tall et al., 2001). 
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4.3. Cl-6 Plays a Role in AChR Clustering 
ely to lie between Agrin 
ynamin, but depends on the activity of the Rho-GTPase Rac1 (Kumari et 
 difference in the 
1, it could be possible that Cl-6 stimulates the degradation 
ean that the downregulation, of Cl-6 results in decreased 
 
It has been shown that MuSK is internalized after Agrin stimulation (Zhu et al., 2008), just 
like other ligand-induced receptor tyrosine kinases, including EGFR (Schlessinger, 2004) and 
Trk Receptors (Zhang et al., 2000). The internalization of activated receptors is promoted via 
ligand binding and leads either to the attenuation of signaling via degradation of the ligand-
receptor complex or signaling from endosomes (Ceresa and Schmid, 2000; Di Fiore and De 
Camilli, 2001). Agrin-mediated endocytosis of MuSK seems to be required for AChR 
clustering (Zhu et al., 2008). Endocytosis, which is characterized by the internalization of 
molecules from cell surface into internal membrane compartments, can be divided into two 
main pathways: the classic, clathrin-mediated endocytic pathway and the nonclassic, clathrin-
independent but lipid-raft-dependent route (Le Roy and Wrana, 2005). Which, of these two 
pathways is used by MuSK is not yet clear, but it has been shown, that MuSK endocytosis 
and AChR clustering is attenuated by the dominant-negative K44A dynamin mutant, which is 
deficient in GTP hydrolysis (Zhu et al., 2008). Additionally, it has been shown, that Agrin 
induces rapid translocation of MuSK into lipid rafts, which is required for downstream 
signaling and AChR clustering (Zhu et al., 2006). Dynamin has been shown to be essential for 
raft-dependent endocytosis and the GTPase activity of dynamin is required for the budding of 
lipid rafts from purified endothelial plasma membranes (Oh et al., 1998). How endocytosis of 
MuSK is actually linked to AChR clustering remains unclear. AChR phosphorylation and 
lustering are relatively slow, suggesting that multiple steps are likc
activation of MuSK and AChR phosphorylation and clustering (Burden, 1998). Nevertheless, 
endocytosis of MuSK seems to be involved in Agrin signaling (Zhu et al., 2008). In muscle 
cells, endocytosis of AChRs is barely detectable, but a significant number of AChRs recycle 
back into the postsynaptic membrane in vivo (Akaaboune et al., 1999; Bruneau et al., 2005; 
Bruneau and Akaaboune, 2006). This suggests, that AChR endocytosis might be mediated by 
a different mechanism (Zhu et al., 2008). Indeed, it turned out, that the endocytosis of AChRs 
s independent of di
al., 2008). The identification of the different internalization pathways used by cells is of 
tremendous relevance, because cells use different internalization mechanisms to control 
signaling, the magnitude, duration and nature of signaling events and receptor turnover. 
 
In this study, it has been shown, that Cl-6 downregulation interferes with AChR clustering at 
the NMS. Therefore, Cl-6 seems to be an important molecule in downstream signaling of the 
Agrin/Lrp4/MuSK pathway. In spite of the necessary role of Cl-6 in AChR cluster formation, 
the way how this is achieved, remains to be determined. Burke et al. could show for the 
EGFR, that the receptor remained active in early endosomes, after internalization, and also 
nteracted with different signaling molecules. Additionally, they observed ai
proteins, which interacted with the EGFR at the surface and in early endosomes. This 
suggests, that internalization is needed for the modulation of receptor signaling. Although 
receptor internalization is the first step in receptor degradation, internalization is not 
necessarily an attenuation process itself (Burke et al., 2001). Although ligand-induced 
endocytosis was originally thought to be a mechanism of receptor inactivation, many studies 
suggest that receptors remain active within endosomes (Wiley and Burke, 2001). 
 
From these observations, the conclusion can be drawn that Cl-6 might function in the 
endocytosis of MuSK. For RIN1 it has been shown, that it stimulates the degradation of 
EGFR by its interaction with Rab5 (Chen et al., 2009). Since Cl-6 has been shown to interact 
ith Rab5 in the same way as RINw
of MuSK via Rab5. This would m
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endocytosis of surface MuSK and therefore, prolonge
duction in the internalization-dependent signaling events. 
d MuSK surface signaling and a 
Since downregulation of Cl-6 
generated to 
tudy the role of Cl-6 during NMS formation, maintenance and function in vivo. 
re
leads to smaller AChR cluster, I propose that the signals, necessary for AChR clustering come 
from within the cell, rather than from the cell surface or that both ways of signaling contribute 
equally to the formation of cluster and that a reduction of one mechanism leads to smaller 
clusters. Consistent with these data, blocking endocytosis using a dominant negative mutant 
of Dynamin 2 leads to the generation of smaller and fragmented AChR clusters upon Agrin-
stimulation (Zhu et al., 2008). Another possibility would be that Cl-6 has no influence on 
MuSK endocytosis, but might just stabilize MuSK at the NMS. This hypothesis is somehow 
supported by the observation, that the interaction of Cl-6 with MuSK is independent of its 
activation status (Michaela Mutzl, Diploma thesis). Further studies will be needed to really 
clarify the role of Cl-6 at the NMS. An important step in this direction would be the 
identification of tyrosine phosphorylated proteins that interact with the SH2 domain of Cl-6. 
The interaction of such proteins would depend on the phosphorylation of these proteins, most 
probably by the Agrin-MuSK signaling pathway. It has been shown that binding of EGF to 
the EGFR activates the receptor, which leads to tyrosine phosphorylation of the EGFR. These 
activated EGFR can then bind to the SH2 domain of RIN1, which couples it to the endocytic 
machinery via its interaction with Rab5 through the Vps9 domain. My third hypothesis, about 
the functional importance of the interaction between Cl-6 and MuSK rests on these data. 
Thereby, interaction of Cl-6 with MuSK is required to target Cl-6 to the NMS, where it can 
interact with other proteins and regulate the endocytosis of proteins via its interaction with the 
SH2 domain. 
 
So far the trafficking of MuSK and the responses it generates are poorly understood. 
Therefore, further research will be needed, to clarify the function and influence of Cl-6 on 
MuSK at the NMS. Recent studies provide strong evidence that receptor trafficking is an 
important mechanism to regulate the specificity of receptor tyrosine kinase (RTK)-generated 
responses (Vieira et al., 1996; Zhang et al., 2000). Therefore, Cl-6 might represent an 
important link between MuSK signaling and endocytosis. 
 
 
4.4. Future Outlook 
 
In the future the consequences of Cl-6 interactions with Rab5 and MuSK have to be 
determined. In particular, it will be important to show that Cl-6 acts as GEF for Rab5. 
Consequently, it has to be tested whether this mechanism plays a role during MuSK 
endocytosis. Additionally, it will be necessary to determine whether the downregulation of 
Cl-6 has any influence on MuSK expression or the amount of MuSK present at the surface. 
Stable muscle cell lines carrying different siRNA constructs will assist in answering this 
question as well as the recent finding that Lrp4 is the Agrin receptor, which allows for the 
determination of MuSK function in heterologous cell systems. This will make it easier to 
determine whether Cl-6 has any influence on MuSK endocytosis or stability. Furthermore,  
Cl-6 knock-out mice and a conditional knock-out in skeletal muscle are being 
s
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5. Materials and Methods 
 
5.1. Chemicals and Reagents 
 
10xPBS PAA 
40% Acrylamide  Roth 
Acetic acid  Roth 
Agar-Agar  Roth 
Alexa594-α-bungarotoxin  Molecular Probes 
Ampicillin  Roth 
Aprotinin Roth 
APS  Roth 
BSA  PAA 
Bromphenol blue  Roth 
Calcium chloride  Roth 
DABCO Roth 
DMEM Sigma 
DMSO  Roth 
EDTA  Roth 
thanol  E Roth 
lycine  Promega 
Roth 
Roth 
Roth 
anamycin  Roth 
owiol 4-88 Roth 
aOH  Roth 
-Lauroylsarcosine Sigma 
P-40  Sigma 
araformaldehyde  FLUKA 
Ethidium bromide  Roth 
FBS  Gibco 
Gelatine  Sigma 
Gel extraction kit Omega 
Geneticidindisulfat (G418)  Roth 
Glutathione-agarose beads Sigma 
lycerol  Roth G
G
HCl  
IPTG 
Isopropanol  
K
LB-broth  Roth 
Leupeptin Roche 
Lumi-Light  Roche 
Lysozyme Sigma 
Maxi prep kit  Omega 
Methanol  Roth 
MgCl2 Roth 
MgSO4  Roth 
Midi prep kit  Omega 
Mini prep kit  Fermentas 
Modifying enzymes  Fermentas 
M
N
N
N
P
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PCR buffer 10x 
PEG  
Sigma 
Roth 
enicillin/Streptomycin  Sigma 
Pepstatin A US biological 
Roth 
Roth 
s  
te  
hydrogen phosphate  
  
100  
 
ld  R 
 Woller (unpublished) 
uz 
rbst (Herbst & Burden, 2000) 
n Fuhrer 
ibody  
otyrosine antibody  
e-pair ladder  
P
Phenylmethylsulfonylfluorid (PMSF) 
 chloride Potassium
Prestained protein ladder (Gene ruler) Fermentas 
Protein A-agarose beads  Roche 
Restriction enzyme Fermentas 
Sodium aceta Roth 
Sodium chlo Roth ride  
Sodium dodecyl sulfate  SERVA 
Sodiumdihyd Roth rogen phosphate  
Sodiumfluoride (NaF)  Fluka Chemika 
Sodium Roth 
Sodium Sigma  orthovanadate 
Taq buffer 10x Fermentas 
Taq DNA polymer BioLaase bs 
TEA  Sigma 
Tris  Roth 
Tris-HCl Roth 
Triton X Sigma -
Trypsin-E GibcoDTA  
Tween 20  Promega 
Vectas VECTOhie
α-Cl-6 ant Barbaraibody  
 Crα-GFP antibody  Santa
α-MuSK antibody  Ruth He
ntibody iaα-MuSK a Christ
tα-myc an Sigma 
sph ignaling p100; Santa Cruz p99 α-pho Cell S
β-Mercaptoethanol  Roth 
1kb DNA bas Fermentas 
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5.2. Oligonucleotides 
 
 
Primer name Sequence (5’→3’) 
Cl-6  primers 
Vps9 EcoRI for CGAATTCGCGG AGC GGCCTGAGGGACAG
Vps9 XhoI rev GCGCT GGCG CGAGCCGTCTTCGATGCCACT
RNAi oligos 
348s GATCCCC TTCGCCAGGTCCTGATGTTGAA AAGA
TTTTA 
GATTCAACATCAGGACCTGGCT
348as AGCTTA GAATCTCTTAAAAGCCAGGTCCTGATGTT TCGAAT AACATCAGGACCT
GGCGGG 
2034s GATCCC TTCAAG
TTTTTA 
CACCCTCTCGCCTGAATCTC AGAGAGATTCAGGCGAGAGGGT
2034as AGCTTA CTCTCTCAAAAACCCTCTCGCCTGAAT TTGAAGAGATTCAGGCGAGAG
GGTGGG 
scramb TTCAAled GATCCCCGGGTTACCAGCGACTATGT GAGAACATAGTCGC 
TGGTAACCCTTTTTA 348s 
scrambled 
348as 
ATGTTCAGCTTAAAAAGGGTTACCAGCGACT TCTTGAAACATAGTC 
GCTGGTAACCCGGG 
scrambled G TTCAAGATCCCCGCCCTCCCACGACTTTCAT AGAATGAAAGTCGT 
GGGAGGGCTTTTTA 2034s 
scrambled CATTCTCT
2034as CG
AGCTTAAAAAGCCCTCCCACGACTTT TGAAATGAAAGT 
TGGGAGGGCGGG 
 
Underlined bases re
 
present restriction sites. 
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5.3. Plasmids 
 
 
Plasmid name oning Reference Description/Cl
Mammalian expression vectors 
pEGFP-Rab5 wt Rab5 wt sequence with a N-terminal GFP-tag. M. Zerial 
pEGFP-Rab5 S34N inal GFP-tag M. Zerial  Dominant negative form of Rab5 with a N-term
pEGFP-Rab5 Q79L Constitutively active form of Rab5 with a N-terminal GPF-tag M. Zerial 
pEGFP Rab7 Rab7 sequence with a N-terminal GFP-tag. C. Bucci 
MuSK-myc ammalian expression vector backbone pRc/RSVr. 
with a myc tag at 10 aa site. 
Backbone from A m
Promoter: RSC LTR; bacteria resistance: ampicillin. Insert 
MuSK 
Invitrogen 
pCMX.PL1_CKII_β The CKII β-subunit S. Hashemolhosseini 
Plasmids for prot in E. coli ein expression 
pGEX-4T-1 Control plasmid. GE Healthcare 
GST-Y2H Cl-6 DNA that was isolated in a Y2H screen was subcloned R. Herb
into the pGEX-3 Vector. It contains aa 200 to 563 of the full-
st 
length construct 
GST-N900 A Cl-6 DNA fragment containing the aa 200 to 479 was 
GEX-2 vector 
R. Herbst
subcloned into the p
 
GST-Δ250 A Cl-6 DNA fragment containing the aa 248 to 563 was R. Herbst 
subcloned into the pGEX-2 vector 
RNAi plasmid 
pSuperior.gfp/neo See plasmid map in Introduction; the siRNA expression 
cassette in all pSUPER and pSUPERIOR vectors are 
completely identical, except for one key feature: a sequence 
modification of the H1 promoter between the TATA box and 
the RNA hairpin transcription start site; 
OligoEngine, 
Brummelkamp et al., 
2002 
 
 
 
5.4. Bacterial Strain 
. coli strain: Rosetta(DE3)pLysS (F- ompT hsdSB(RB- mB-) gal dcm λ(DE3 [lacI lacUV5-T7 
gene 1 ind1 sam7 nin5) pLysSRARE (CamR)) 
 
E
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5.5. Cloning of GST-Fusion Proteins 
 GST-Cl-6 
 pEGFP/N3-Cl6 fl was cut with KpnI and the ends were removed 
 pol EcoRI was pe The vector 
 c lu igated into 
aI.
T-Vps9
 
For this construct quence was amplified by PCR using the 
 d Vps9 XhoI rev. The resulting PC n 
d into a pGEX-4T-1 vector that had been cut the same 
d that this construct lacks the helical bundle and is 
ot the fu omain of Cl-6 (Delprato et al., 2004). 
5.5.3. GST-Vps9
For this construct t mHI and the ends were filled in 
now frag r The vector 
pGEX-4T-1 was cu  ligation of these two fragments led to the 
 the BamHI/SmaI restriction site. This construct contains the Vps9 domain 
5.5.4. GST-Vps9
 
or this construct the GST-Y2H construct was cut with EcoRI and BamHI and ligated into the 
GEX-1 vector that had been cut the same way. This construct just consists of the last helix of 
e Vps9 domain and should therefore be not functional at all. 
 
ith SmaI and hat had been cut the same way. 
his construct was used as a control for the GST pull-downs with MuSK, because it has been 
hown, that CKII strongly interacts with MuSK (Cheusova et al., 2006). 
.5.6. GST-RIN1 
or this construct BS-RIN1 was cut with EcoRI and XhoI and ligated into the pGEX-4T-1 
ector that had been cut the same way. This construct was used as a control for the GST pull-
owns with Rab5, because it has been published that RIN1 interacts with Rab5 and 
preferentially with the dominant-negative mutant of Rab5, S34N (Tall et al., 2001). 
 
5.5.1.
 
For the Cl-6 insert the vector
using T4 DNA ymerase. Then a second digestion with rformed. 
pGEX-5X-2 was ut using SmaI and EcoRI. Cl-6|EcoRI, KpnI b nt was l
pGEX|EcoRI, Sm
 
 
5.5.2. GS  
the Vps9 part of the Cl-6 se
following primers: Vps9 EcoRI for an R fragment was the
cut with EcoRI and XhoI and ligate
way. Crystallization studies reveale
therefore n nctional Vps9 d
 
a 
 
he GST-Vps9 construct was cut with Ba
using Kle ment. Then a second digestion with EcoRI was pe
t using SmaI and EcoRI and
formed. 
destruction of
lacking the last helix. 
 
b 
F
p
th
5.5.5. GST-CKII 
 
For this construct the Casein Kinase II (CKII) containing vector pCMX.PL1_CKII_β was cut 
 XhoI and ligated into the pGEX-4T-1 vector tw
T
s
 
5
 
F
v
d
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5.6. Plasmid Preparation from E. Coli 
le Plasmid Preparation 
ufacturer. 
e Plasmid Preparation 
Plasmid Preparation 
260nm. 
.7. Manipulation of DNA with Enzymes 
ied by Fermentas or New England Biolabs and used as suggested by the 
anufacturer. Digestions were mostly carried out in a 20μl volume using 0.5-1μl restriction 
linearized plasmids 1μl SAP (shrimp alkaline phosphatase, 1U/μl) 
digestion, followed by a 1h incubation period at 37°C. 
 
5.6.1. Small Sca
 
1.5-3ml of an overnight culture (in LB medium containing 50μg/ml Ampicillin or 30μg/ml 
Kanamycin) were centrifuged at maximum speed in a table-top centrifuge and plasmids were 
isolated using the Fermentas Gene JetTM Plasmid Miniprep kit. All steps were carried out as 
suggested by the man
 
5.6.2. Middle Scal
 
100-200ml of an overnight culture (in LB medium containing 50μg/ml Ampicillin or 30μg/ml 
Kanamycin) were centrifuged at 5000g (SLA-1500 rotor) and plasmids were isolated using 
the Omega biotek Plasmid Midiprep kit. All steps were carried out as suggested by the 
manufacturer. The DNA concentration was determined by measuring an aqueous dilution at 
260nm. 
 
5.6.3. Large Scale 
 
200-400ml of an overnight culture (in LB medium containing 50μg/ml Ampicillin or 30μg/ml 
Kanamycin) were centrifuged at 5000g in a Sorvall centrifuge using the SLA-1500 rotor. 
Plasmids were isolated using the Omega Biotek Plasmid Maxiprep kit. All steps were carried 
out as suggested by the manufacturer. The DNA concentration was determined by measuring 
an aqueous dilution at 
 
 
5
 
5.7.1. Restriction Enzyme Digestion 
 
Enzymes were suppl
m
enzyme solution and approximately 0.5 to 1μg DNA. 
 
5.7.2. Dephosphorylation of DNA 
 
For dephosphorylation of 
was added right after 
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5.7.3. Filling in Ends with Klenow Polymerase 
Klenow polymerase fills in sticky ends and makes them blunt. 0.5μl Klenow polymerase 
ogether with 1.5μl dNTPs (2mM). The vial 
as incubated at 37°C for 15min, afterwards the enzyme was heat-inactivated by putting the 
After digestion the DNA was run on a 0.8-2% agarose gel/1xTAE containing 2μl EtBr per 
ing the gel onto a UV source. The right 
ands were excised from the gel and purified using a Gel Extraction kit. All steps were 
50x TAE: 242g Tris base 
 volume adjusted to 1l with dH2O 
igation reactions were always carried out in a 20μl volume with a molar ration of vector to 
insert of approximately 1:3, except for very small inserts, which were used in higher excess. 
restriction enzymes that produced the 
ed by combining vector and 
sert DNA in an Eppendorf tube and adding 1μl T4 DNA ligase (5u/ml), 2μl 10x T4 buffer 
r at least 4h or over night at RT, the whole 
teria. 
d with bacteria and left on a shaker at 37°C over 
ight. 1ml of this overnight culture was added to 100ml of LB-Medium, the resulting culture 
d the pellet was 
mediately resuspended in 10ml ice-cold TBS buffer. Aliquots of competent bacteria were 
ozen and stored at -80°C. The quality of the competent bacteria was assayed by 
ansforming them with a plasmid carrying an antibiotic resistance gene. High fidelity bacteria 
hould yield at least 106 colonies per 1μg DNA. The bacteria alone were also put on LB-
plates, which contained antibiotics, to test that there is no contamination in the preparation. 
 
(5U/μl) were added directly to the restriction mix t
w
vial to 75°C for 10min. 
 
5.7.4. Isolation of DNA Restriction Fragments 
 
50ml of gel. The bands were visualized by subject
b
carried out as suggested by the manufacturer. Concentrations of isolated DNA fragments were 
estimated by loading 1μl aliquots onto an agarose gel and comparing the resulting bands to 
the 1kb DNA base pair ladder, that was loaded at known concentration. 
 
 
 
  57.1ml acetic acid 
  100ml 0.5M EDTA 
 
 
 
 
5.7.5. Ligation of DNA 
 
L
Prior to ligation, vector and insert were digested with 
e or compatible cohesive ends. The ligation was performsam
in
and dH2O up to 20μl. After an incubation fo
gation mix was transformed into competent bacli
 
 
.8. Generation of Competent Bacteria 5
 
3ml LB without antibiotics were inoculate
n
was incubated on a shaker at 37°C until the OD600 reached a value between 0.3 and 0.6. Then 
the bacteria were centrifuged at 5000rpm (SLA-1500 rotor) for 5min an
im
fr
tr
s
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 TBS buffer: 10% PEG 
  5% DMSO 
 ffer: 
 
 
trophoresis and Western Blot Analysis 
y the destaining was continued at 4°C 
ver night. 
or Western blot analysis the gel was placed on top of a PVDF-membrane (which was 
right before use) between two transfer 
A was applied per gel. The 
roteins were allowed to migrate onto the membrane for 80-90min. Afterwards, the 
he 
  10mM MgCl2
  10mM MgSO4
 
 
 
5.9. Transformation of Competent Bacteria 
 
In an Eppendorf reaction tube 20μl ligation mix, 20μl 5xKCM buffer, 60μl dH2O and 100μl 
competent bacteria were mixed. Then the tube was placed on ice for 30min, afterwards on 
42°C for a 2min heat shock and then put back on ice again. After the addition of 900μl LB 
medium without antibiotics the tube was incubated at 37°C in a water bath for 30min. Then 
the cells were pelleted and ~1ml of the supernatant was discarded. The rest was plated on 
selective media. 
 
 
 5xKCM bu  0.5M KCl 
  0.15M CaCl2
  0.25M MgCl2
 
 
 
5.10. Protein Gel Elec
 
Different percentage polyacrylamide gels were prepared, according to the size of proteins to 
be analyzed. Samples were mixed with 4xSDS loading dye and loaded into the gel slots. Then 
gels were run at 100-130V in 1xRunning Buffer. After separation of the proteins, the gels 
were taken out of the electrophoresis apparatus and immediately put into transfer buffer for 
Western blot analysis or into Coomassie staining solution. 
For the Coomassie staining procedure the gels were approximately 30min incubated in the 
Coomassie staining solution. Afterwards the gels were destained in Coomassie destain until 
he protein-bands became visible at RT and preferablt
o
F
incubated in methanol and washed in transfer buffer 
buffer-drained papers in a blotting apparatus and a current of 50m
p
membrane was immediately put into TBS-Tween for washing. For further analysis the 
membrane was blocked. This was achieved by incubating the membrane on a shaker at room 
temperature in a 5% BSA/TBS-Tween solution for 2h or in a 5% instant milk powder in TBS-
Tween solution for 1h. The primary antibody, stored at 4°C in 5% BSA + 0.1% NaN3 in TBS-
Tween, was then added to the membrane. The membrane was then incubated with the 
antibody over night at 4°C. The next day, the membrane was washed 3 times for 10min with 
TBS-Tween and then the secondary antibody, a horse reddish peroxidase conjugated antibody 
was added, diluted in 5% instant milk powder in TBS-Tween. After 1h incubation, the 
membrane was washed another 3 times for 10min with TBS-Tween and incubated with Roc
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L ight, Western blot, horse reddumi-L ish peroxidase substrate. The bands were visualized by 
he membranes to BIO-RAD Fluor-STM MultiImager. Bands were analyzed using 
Quantity One – 4.1.1 Software. To loosen the antibody binding, blots were 
anes with 10% acetic acid for 2h on a shaker and 
fterwards washing the blots with TBS-Tween or by incubating the membranes for 5min in 
.2M NaOH and washing with dH2O before and afterwards. Then the blots were reused for 
nother antibody reaction. 
To visualize the protein bands on the membranes, the blots can be stained with Ponceau 
2O. Afterwards, the blots can be 
ompletely destained with TBS-Tween and can then be used for antibody reactions again. 
8% β-mercaptoethanol 
   8% SDS 
% glycerol 
phenol blue 
g Tris base 
 72g glycine 
 dissolved in almost 1l dH2O 
 5g SDS were added and the volume adjusted to 1l 
 29g Glycine 
 1.5M NaCl 
subjecting t
BIO-RAD 
stripped either by incubating the membr
a
0
a
solution for a few minutes at RT and then destained with dH
c
 
 
5.10.1. Solutions and Gels 
 
 4xSDS Loading Buffer: 240mM Tris.Cl pH6.8 
  
   40
   brom
 
 5xRunning Buffer: 15.05
 
 
 
 
 10xTransfer Buffer: 58g Tris 
 
  5g SDS 
  filled with dH2O to 1l 
 
 1xTransfer Buffer: 50ml 10xTransfer Buffer 
  50ml methanol 
  400ml dH2O 
 
 10x TBS-Tween: 100mM Tris.Cl pH8 
  
   0.5% Tween 20 
 
 Coomassie Staining: 225ml methanol 
  50ml acetic acid 
  225ml dH2O 
  1,25g Coomassie Brilliant Blue was added to the solution 
 
 Coomassie Destaining: 90ml methanol 
  20ml acetic acid 
  90ml dH2O 
 
 Ponceau Solution: 0.5g Ponceau 
  500ml 1% acetic acid 
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Running Gel 
PAA-Gels 
 7.5%   10%   12.5%  
total volume [ml] 5 10 20 5 10 20 5 10 20 
40% AA mix [ml] 0.94 1.88 3.76 1.25 2.5 5 1.55 3.1 6.2 
1.5M Tris/0.5M HCl [ml] 1.25 2.5 5 1.25 2.5 5 1.25 2.5 5 
dH2O [ml] 2.7 5.4 10.8 2.4 4.8 9.6 2.1 4.2 8.4 
10% SDS [μl] 50 100 200 50 100 200 50 100 200 
APS [μl] 50 50 100 50 50 100 50 50 100 
TEMED [μl] 5 10 20 5 10 20 5 10 20 
 
Stacking Gel PAA-Gels 
5% 
to e [ml] 5 10 tal volum
40% AA mix [ml] 1.25 0.625 
0.02M M Tris.Cl [ml] 1. Tris/0.48 25 2.5 
dH2O 3.[ml] 025 6.05 
10% SDS [μl] 50 100 
A 100 PS [μl] 50 
TEMED [μl] 10 5 
 
 
 
5.11. Polymer eaction (PCRase Chain R ) 
NA wa  DNA ers 
h a c .25μl PCR-buffer, 0.5μl 10mM 
polymerase. Th with water to a final volume of 
n mix was incu  at 95°C to denaturate the DNA, and then 
 95°C, 30sec at 60±7.5°C (gradient) 
nd 3 at on of the DNA which was 10min at 
72°C.
ion Proteins in E. Coli 
he E. coli strain Rosetta was transformed with the expression plasmids that encode for a 
LB medium supplemented with 
ed 1:25, incubated shaking at 
eached a value of approximately 0.8-0.9. 
rotein production was induced by the addition of 0.5mM IPTG and the culture was 
cubated fterwa ia were chilled on ice and centrifuged for 
5min a 5000g (SLA-1500 rotor spended with ice-cold 1xPBS+1% 
 
D s amplified from a  template (plasmid or cDNA) using two specific prim
rimer wit 1(0.625μl of each p oncentration of 10μM), 
filled up dNTPs, 0.1μl Taq e mixture was 
2.5μl. The reactio bated for 120sec1
there were 30 cycles which contained 3 steps: 30sec at
a  72°C. After th longati0sec at there was a final e
 
 
 
5.12. Expression and Purification of GST-Fus
 
T
GST-fusion protein. One single colony was grown up in 
50μg/ml Ampicillin overnight. This pre-culture was dilut
220rpm at 37°C and left growing until OD600 r
P
in  for another 2h. A rds, the bacter
1 t ). The pellet was resu
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Triton. Per ml resuspension 20μl lysozyme (50mg/ml) and 2μl PMSF solution were added. 
e of the 
ll the samples were then a d twi  for 10sec with 20 c on ween. 
 samples were entrif d f 5min at 15000g either in an Eppendorf 5415 D 
-34 roto upernatant was then added to glutathione-
hich had be sh it B  n f  thre es before use. In 
 sarkos  th sat he v e o e supernatant was doubled with 
 Triton to decre the ko m p we en 
 a rotating devic  4°C 1h n the sam  we nt ged 5m he 
ne agarose beads we hen she m ith BS  T  fo min en 
e made. One aliq t wa ed f ine the concentration and 
rified protein by p rform assie staining, while the ot
 liquid nitrogen and were stored at -80°C for later use. 
 
S: 1.37M NaCl 
27m
3m a2 4
4m H
.13. Cell Culture 
.13.1. HEK-293T and COS-7 Cells 
M supplemented with 10% FBS and 
% penicillin/streptomycin (=general medium, GM). The incubator was adjusted to 37°C and 
led) constructs were generated by Michaela Mutzl during her diploma thesis. 
herefore C2HG cells were transfected with this constructs using Lipofectamin. Afterwards, 
ingle clone colonies were picked and frozen in liquid nitrogen. 
C2HG cells stably expressing different siRNAi constructs and C2C12 cells were grown in 
 
enicillin/streptomycin (= general medium, GM). Additionally, 700μg/ml G418 were added 
The pellets were lysed on ice for 1h. After that 0.25% sarkosyl was added to som
samples. A  sonic te ce se ice inbet
Afterwards, the  c uge or 1
centrifuge or with a SS
agarose beads, w
r. The cleare
en wa
d s
h 1xPed w S+1% Trito or e tim
case of the addition of yl to e ly e, t olum f th
1xPBS+1% ase  sar syl a ount to 0.125%. The sam les re th
incubated on e at  for . The ples re ce rifu  for in. T
glutathio re t  wa d 3 ti es w  1xP +1% riton r 15 . Th
aliquots wer
urity of pu
uo
e
s us
ing Coom
or SDS-PAGE to determ
p
in
her aliquots were put 
 
 10xPB
  M KCl 
  4
  1
M N
M K
HPO
PO2 4
 
 
 
5
 
5
 
HEK-293T cells and COS-7 cells were grown in DME
1
6% CO2. Cells were split every two days when they were about 80-90% confluent. 
 
5.13.2. C2 Muscle Cells 
 
C2HG cells stably expressing different RNAi (empty, 348, 348 scrambled, 2034 and 2034 
scramb
T
s
DMEM supplemented with 15% FBS, 0.25% chicken embryonic extract and 1%
p
to the GM medium of stable cell lines. The incubator was adjusted to 37°C and 6% CO2. Cells 
were splitt every two days when they were about 80-90% confluent. For differentiation of C2 
myoblasts into myotubes cells were plated on gelatine coated dishes (C2HG: ~1.3*105 
cells/3.5cm dish; C2C12: ~3*105 cells/10cm dish) and differentiation was started the next day 
by switching to DMEM supplemented with 2% HS and 1% penicillin/streptomycin (= 
differentiation medium, DM) at ~90% confluency. DM was changed every day for 3-4 days 
when the differentiation into myotubes was completed. 
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5.13.3. Freezing of Cells 
 
A 10cm plate of happily growing cells that were about 60-70% confluent was trypsinized. 
The cells were washed off the plate with 5ml GM, then centrifuged for 5min at 1500rpm. The 
cell pellet was well resuspended in 1ml freeze medium (GM + 10% DMSO). Cells were 
frozen at -80°C and can be later put into a liquid nitrogen tank for long-time storage. 
 
5.13.4. Transfection of HEK-293T Cells and COS-7 Cells by Ca2+ DNA 
Precipitation 
 
2xBBS solution and the 0.25M CaCl2 solution were thawed quickly and placed at room 
temperature. For every 10cm plate 20μg DNA was used in total and pipetted into a round 
ottom polystyrene tube. Then, 875μl 0.25M CaCl2 were added and the solution was mixed. 
ube was vortexed, followed by an incubation 
tion step, the DNA mix was added drop-wise 
~15-1 e growth medium was changed to remove the 
he cell
2xBBS:  80ml sterile ddH2O 
 5.6ml 5M NaCl 
5.0ml 1M BES 
150μl 1M Na2HPO4
 pH adjusted to 6.95 
l 
2 cells were starved for 2.5-3h and treated with Agrin 4.8 or 0.0 for 30min before cell lysis. 
e same for all different cell types. 
lates were put on ice and the growth medium was aspirated. 
he cells were washed twice with ice-cold PBS. Afterwards, NP-40 lysis buffer containing 
 plate and transferred into an 
 in dH2O 
b
Afterwards, 875μl 2xBBS were added and the t
aat room temperature for 11min. After this incub
ion thon top of the cells. 7h after transfect
precipitate and let t s recover. 
 
 
 
 
  
  
 
  volume raised to 100m
 
 
5.13.5. Preparation of Cell Lysates 
 
C
The lysis procedure itself was then th
After incubation at 37°C the p
T
protease inhibitors was added (1ml per 10cm plate, 400μl per 6cm plate, 100μl per 3.5cm 
plate). The protease inhibitors Leupeptin, Aprotinin, Orthovanadate, Pepstatin and PMSF 
were added to the lysis buffer right before usage. For lysis to occur, plates were left on a 
shaker at 4°C for 10-15min. Then the cells were scraped off each
Eppendorf tube. Lysates were centrifuged at 4°C for 10min at maximum speed in a table-top 
centrifuge. The supernatants were transferred into new centrifugen tubes. Samples were either 
used immediately for further analysis or frozen in liquid nitrogen and stored at -80°C. 
 
 
 NP-40 lysis buffer: 1% NP40 
  5mM EGTA 
  50mM NaCl 
  30mM TEA, pH 7.5 
  50mM NaF 
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5.14. GST Pull-Down 
 
Cell lysate aliquots of 350-1000μl were incubated with the respective GST-fusion proteins 
which were already bound to glutathione-agarose beads on a rotating device. After 4-18h 
incubation the lysates were centrifuged for 1min at maximum speed in an Eppendorf 5415 D 
centrifuge. The glutathione-agarose beads were washed 3-4 times with 1ml lysis buffer for 2-
5min. Bound proteins were eluted with SDS sample buffer and subjected for further analysis 
arose beads were washed 3 times using 1ml lysis buffer. 
DS sample buffer and subjected for further analysis to 
DS-PAGE and Western blotting. All steps were carried out at 4°C. 
 of A
table tr sfected C2 cell ated 3.5cm dishes were treated with Agrin 
.8 for 8 or 16h. As a control cell were treated with Agrin 0.0 for the same time. After that the 
ells were incubated with Alexa-594 conjugated α-bungarotoxin for 60min. Then, the cells 
 before fixation with 2% PFA in PBS for 10min 
2min, plates were mounted onto glass slides in 
uanti R ngth and number was done using the Metamorph 
of the myotubes were taken using the 63x 
he Cy3 filter clusters on the surface of myotubes. The 
nd myotube le  by applying a line across the cluster using 
ion was done in a double-blind manner. The 
 clusters was n micrometers. 
1
to SDS-PAGE and Western blotting. All steps were carried out at 4°C. 
 
 
5.15. Immunoprecipitation 
 
Cell lysate aliquots of 500-1000μl were incubated with the respective antibody on a rotating 
device. After 4-16h incubation 20-30μl protein A agarose was added and incubated for 1-1.5h 
on a rotating device. Lysates were centrifuged for 1min at maximum speed in an Eppendorf 
5415 D centrifuge. The protein A ag
ound proteins were eluted with SB
S
 
 
5.16. Staining ChRs 
 
S an s cultured on gelatine-co
4
c
were washed twice with PBS for about 2min
at RT. After another two washing steps for 
Vectashield mounting medium or Mowiol supplemented with DABCO. After that the plates 
were viewed on a fluorescence microscope using an excitation wavelength of 546nm. 
 
 
 4% PFA/PBS: 0.8g PFA were dissolved in 20ml 1xPBS 
  100μl 0.5M NaOH to reach pH7 
  The solution was gently heated and stirred until clear. 
 
 
 
5.17. Quantification of AChR Clusters 
 
Q fication of the ACh  cluster le
Imaging Software (Molecular Devices). Pictures 
objective and t  to visualize AChR 
ChR uster aA cl ngth were determined
the free hand tool of the software. The quantificat
length of AChR presented i
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6. Abbreviations 
PS ammoniumperoxidisulfate 
TP adenosine triphosphate 
p base pair 
BS BES buffered saline 
ES N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid 
LAST basic local alignment research tool 
SA bovine serum albumin 
a Dalton 
MEM Dulbeco’s Modified Eagles Medium 
MSO dimethylsulfoxide 
NTPs deoxyribonucleoside triphosphates 
. coli Escherichia coli 
DTA ethylenediaminetetraacetate 
tBr ethidium bromide 
BS fetal bovine serum 
DP guanosine diphosphate 
EF guanine nucleotide exchange factor 
FP green fluorescent protein 
ST glutathione S-transferase 
TP guanosine triphosphate 
 hour 
EPES 2-[4-(2-Hydroxyethyl)-1-piperazinyl]-ethanesulphonic acid 
TG isopropylthio-β-D-galactoside 
b kilobase 
Da kiloDalton 
B Luria-Bertani Medium 
CS multiple cloning site 
in minute 
P-40 Nonidet P-40 
t nucleotide 
D optical density 
ligo oligonucleotide 
AGE polyacrylamide gel electrophoresis 
BS phosphate-buffered saline 
CR polymerase chain reaction 
EG polyethylene glycol 
FA paraformaldehyde 
MSF phenylmethylsulfonylfluoride 
Tyr phosphorylated tyrosine 
VDF polyvinylidene difluoride 
H RIN homology 
T room temperature 
DS sodium dodecyl sulfate 
ec second 
SH2 Src homology 2 
TAE tris-acetate-EDTA 
TBS tris-buffered saline 
 
A
A
b
B
B
B
B
D
D
D
d
E
E
E
F
G
G
G
G
G
h
H
IP
k
k
L
M
m
N
n
O
o
P
P
P
P
P
P
p
P
R
R
S
s
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TBE tris-borate-E
TE tris-EDTA 
DTA 
EA triethanolamine acetate 
 
e 
g 
T
TEMED N,N,N,N-tetramethylethylene diamine
Tris tris (hydroxymethyl) aminomethan
Vps9 vacuolar protein sortin
Y2H Yeast-2-hybrid 
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